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1. Introduction
The dilution of commercially available topical corticosteroid formulations is a common
practice done in many countries in response to physicians’ requests. The intuitive
expectation is that dilution would reduce the activity of the corticosteroid formulations
to meet the needs of the patients and at the same time enable the physician to
restrict prescribing to well known corticosteroid molecules. However, predicting the
extent to which activity is reduced when a topical corticosteroid formulation is diluted
is no simple task, besides this practice is associated with a number of dangers. In
particular, there is a risk of accelerating chemical and physical decomposition,
facilitating microbial contamination and interfering with the biopharmaceutical profiles
of the formulations.
The biopharmaceutical incompatibilities, which may arise from the inappropriate
selection of the vehicle used for dilution, are of special importance as the
sophisticated nature of the commercially available bases may imply that any changes
in concentration or components of the base may affect the rate of release of the
corticosteroid from the final preparation. It would therefore appear that
extemporaneous dilution of proprietary topical corticosteroid formulations could result
in a disturbance of the equilibrium of base components necessary for optimum
release of active ingredients.
The aim of this study was to investigate to what extent the drug release from topical
semisolid preparations as well as drug permeation through skin are influenced by
dilution. For this purpose water-containig hydrophilic ointment DAB 1998 (WHS) with
1% hydrocortisone was chosen as a model cream base. It was diluted with various
hydrophilic and lipophilic vehicles with and without water content all selected from the
German Pharmacopoeia, DAB 1998. The following aspects were investigated:
a) The influence of base type used for dilution and degree of dilution on the
release of hydrocortisone from topical semisolid preparations.
b) Factors affecting drug release such as drug solubility in the base, water
content and viscosity in order to interpret the different liberation profiles.
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c) Effect of base type and dilution on drug permeation through excised human
stratum corneum and the correlation between liberation and permeation
studies.
d) The interactions between the cream bases used for permeation with the
structure of stratum corneum and the subsequent influence on the
permeability of stratum corneum.
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2. Theoretical part
2.1. Hydrocortisone
Hydrocortisone was introduced 1952 by Sulzberger and Witten as the first topically
applied corticosteroid which represented a great advance on previously available
therapies (Structure, Fig. 2.1.)
However, the halogenation of corticosteroids in the positions C-6 and C-9, first
introduced by triamcinolone acetonide began the revolution which cumulated in the
appearance of the very potent agents now available.
Hydrocortisone is classified as a low potency corticosteroid with comparable efficacy
to dexamethasone and flumethalone (Cornell and Stoughton, 1984).
Corticosteroids posses antiinflammatory activity, immunosuppressive properties and
antiproliferative actions (Miller and Monro, 1980) being very useful in the local
treatment of eczema, dermatitis, pruritis, insect bites and psoriasis.
Antiinflammatory effects result from decreased formation, release and activity of the
mediators of inflammation (e.g. kinines, histamine, prostaglandins and leukotriens)
which reduce the initial manifestations of the inflammatory process. Moreover,
corticosteroids inhibit cell migration to the area of injury and also reverse the dilation
and increased vessel permeability in the area resulting in decreased access of cells
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to the sites of injury. This vasoconstrictive action decreases serum extravasation,
swelling and discomfort (Gilman et al., 1990).
Additional research demonstrated that glucorticoids also induce the antiinflammatory
protein, lipocortin. This protein inhibits the enzyme phopholipase A2 which inhibits
the synthesis of prostaglandins and lipoxygenase products (Schwiebert et al., 1996).
Immunosuppressive properties decrease the response to delayed and immediate
hypersensitivity reactions. This results from inhibition of the toxic effect of antigen-
antibody complexes that precipitate in vessel walls creating cutaneous allergic
vasculitis. Glucorticoids also inhibit the action of lymphokines target cells and
macrophages which together produce allergic contact dermatitis reactions.
Additionally, the access of T lymphocytes and macrophages to target cells may be
prevented by corticosteroids (Gilman et al., 1990).
Antiproliferative effects reduce hyperplastic tissue characteristics of psoriasis.
Topical hydrocortisone is ineffective unless absorbed through the skin. Therefore,
regional variation in skin thickness and the presence of hair follicles may influence
steroid absorption. Areas with increased permeability (scrotum, eye lids, ears, scalp
and face) may respond better to topical hydrocortisone application than those areas
with thicker stratum corneum (palms and soles). Factors that may facilitate steroid
absorption are hydration, humidity, occlusive wrapping and damaged skin (Generali,
1985).
Ointments, for their soothing effect, are more suitable for the treatment of dry, scaly
areas as well as thick and lichenified lesions. Creams and solutions are preferred for
acute and subacute dermatoses, they may be used on moist skin areas (Drake et al.,
1996). Hairy areas, particularly the scalp, are best treated with aerosols and lotions
(Generali, 1985).
The potency of topical corticosteroids is determined mainly by the McKenzie-
Stoughton vasoconstrictor assay (McKenzie and Stoughton, 1962). The
vasoconstriction caused by topical corticosteroids was taken as the extent of
absorption of corticosteroids in the skin since the degree of vasoconstriction,
recognizable on the blanching effect, usually correlates well with the extent of clinical
efficacy.
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Enthusiasm for the highly effective topical corticosteroids was at its peak during the
1960s and 1970s. However, the appearance of the very serious adverse effects has
created confusion and prejudice against all steroid-containing preparations which are
still of considerable concern. The most common adverse effects of topical
corticsteroids are:
x Atrophy
x Impaired wound healing
x Acneiform eruptions
x Hypopigmentation
x Photosensitivity
x Superinfectious-skin
x Contact dermatitis
x Systemic absorption with systemic adverse effects (Cushing-Syndrom,
adrenal suppresion, growth retardation and many others)
In recent years much care has been taken to re-establish the image and certainly
much effort has been done to improve the understanding of pharmacological and
clinical aspects of topical corticosteroids (Maibach and Surber, 1992).
2.2. Semisolid dosage forms
Dermatological preparations are classified into liquid systems including emulsions,
solutions and suspensions, solid systems (powders) and semisolid formulations.
Semisolid preparations are dosage forms characterized by being spreadable in a
temperature range between room temperature and skin temperature. They are
applied on the skin as well as on mucous membranes (Junginger, 1992). Semisolid
preparations are considered to be colloidal systems possessing a gel structure.
Münzel (1953) defined semisolid dosage forms generally as plastic gels for
cutaneous application. The plastic behaviour of these systems is characterized by the
existence of a yield stress after which the system begins to flow.
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Ointments are water-free semisolid preparations. They are classified according to
DAB 10 into three general groups:
(1) hydrocarbon bases (hydrophobic ointments), (2) absorption bases, (3) water-
soluble bases (hydrophilic ointments).
Hydrocarbon bases are lipophilic in nature containing no polar components. Aqueous
preparations may be only mechanically incorporated with difficulty in small amounts
e.g. petrolatum, triglycerides and waxes. Absorption bases contain in addition to the
lipophilic components also emulsifiers, which could be either w/o-emulsifiers e.g in.
wool fat ointment or o/w-emulsifiers e.g. in hydrophilic ointment permitting thereby the
incorporation of water resulting in the formation of w/o creams or o/w creams,
respectively. Water soluble bases are composed of components completely miscible
with water. They are characterized by the absence of any oleagenous materials e.g.
propylene glycol ointment.
Creams are ointments in which an aqueous phase is incorporated. In the classic o/w
creams the water is immobilized in the cream by either of two ways. On the one hand
water could be bound mechanically through capillary forces and supportive gel
structure. On the other hand, water could be fixed inside the hydrophilic gel phase
through interfacial potential (Junginger, 1984). In contrast, in classic w/o creams e.g.
water-containing wool fat ointment the aqueous phase is incorporated in the form of
droplets inside the base similar to emulsions (Junginger, 1992). Amphiphilic
ointments are considered to be a transition between o/w and w/o creams.
Gels are one-phase semisolid preparations consisting mainly of a liquid fixed by a gel
building substance. Gels are also differentiated into hydrophilic and lipophilic gels
according to the type of liquid used (Bauer et al., 1997).
Pastes are also considered as semisolid dosage forms defined as highly
concentrated suspensions (Bauer et al., 1997).
The selection of the appropriate base depends greatly on the state of disease and
the desired effect. A cooling, drying and antiinflammatory effect is suitable for acute
and subacute cases, therefore creams and lotions are to be utilized (Drake et al.,
1996). In contrast, occlusion achieved by the application of lipophilic bases enhances
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the moisturizing effect of the skin through inhibition of evaporation of sweat and
thereby promotes drug absorption. Lipophilic bases are therefore suitable for chronic
cases. The selection of the base also depends on the skin type. Hydrophilic bases
suite seborrhoic skin while lipophilic vehicles are considered to be compatible with
sebostatic skin (Thoma, 1983).
2.3. Viscoelasticity
When a probe is stressed to above its yield stress it undergoes deformation. After
removal of the stress the ideal viscous bodies retain the deformation, whereas the
ideal elastic bodies regain their original state instantly and completely as before
deformation. In these bodies the deformation energy is saved and reused afterwards
for the recovery (Memory-Effect). A state between ideal viscous and ideal elastic is
represented by viscoelastic bodies. They are characterized by possessing both
elastic and viscous properties. After removal of the stress they are almost completely
recovered but it needs longer time.
Viscoelastic bodies are characterized either by creep experiments or by oscillatory
tests (Davis, 1974). In creep experiments the strain J is recorded as a function of time
for a given stress W value. For elastic systems the deformation returns to zero after
removal of the stress, whereby viscous systems remain at their maximum strain
value. Viscoelastic systems show only a back-deformation of the elastic part.
Viscoelastic systems react as elastic bodies when exposed to stress for short time
intervals, whereas the viscous properties appear only if the probe is exposed to
stress for longer time.
In oscillatory tests the system is exposed to oscillating (swinging) constant stress. At
low stress values the structure of the system remains intact i.e. all parameters which
characterize the system are constant. If the system is overstressed, the structure will
be disturbed and the parameters drastically change.
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The range of stress values in which the structure of the system is undisturbed is
called viscoelastic range. This range varies from one system to the other and must
be determined prior to the actual oscillatory test.
In oscillatory measurements the system is characterized by the following parameters:
Elastic modulus (storage modulus) G’
It represents the quantity of energy reversibly stored in the system, therefore it
characterizes the elastic behaviour of the probe.
Viscous modulus (loss modulus) G”
It represents the quantity of irreversibly lost energy, therefore it characterizes the
viscous behaviour of the probe.
Complex modulus G* = G’ + iG”
Phase angle G
It is the phase angle by which the stress wave is shifted with respect to the strain
wave.
- for ideal elastic bodies J and W are in phase i.e. G is 0°
- for ideal viscous bodies there is a phase angle shift G of 90°
- viscoelastic bodies show a phase angle shift of 0° < G < 90°, therefore systems
having a phase angle G < 45° indicate exceeding elastic properties, whereas
G > 45° indicate exceeding viscous behaviour.
- tan G (loss factor) = G´´/G´, indicating the ratio between the amount of
dissipated and the stored energy and thus between viscous and elastic
portions of the sample
Complex viscostity K*
It is a measure of the viscosity of the viscous as well as the elastic parts of the probe.
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2.4. In vitro release of drugs from topical products
In vitro release tests serve primarily as a quality control tool to ensure batch-to-batch
uniformity and screen experimental formulations during product development. Neither
universal release testing procedure nor universal test conditions exist. Rather, the
release test must be tailored to a formulation i.e. suitable test conditions can usually
be developed.
Generally, in the release test a layer of the semisolid dosage form is placed in
contact with a reservoir and diffusion of drug out of the semisolid and into the
medium of reservoir is followed. In most instances diffusive communications between
the delivery system and the reservoir is through a membrane to keep the product and
the receptor medium physicochemically distinct. According to suggestions of FDA,
membranes are selected for use which: a) are commercially available (the practical
way to assure reproducible membrane properties over time), b) have little capacity to
bind a drug, c) have little tendency to interact with the releasing medium and d) offer
the least possible diffusional resistance (Flyn et al., 1999).
The diffusion coefficient is taken as a parameter to describe drug release. It can be
calculated from the Higuchi equations (Higuchi, 1967) but one should distinguish
between “solution systems” (Eq. 2.1.), in which the drug is completely dissolved in
the semisolid system and “suspension systems” (Eq. 2.2.), in which the drug is rather
suspended in the base.
Release from solution systems
S
tDCAQ s  02 (Eq. 2.1.)
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Release from suspension systems
tCCDAQ ss  02 (Eq.2.2.)
Q= Cumulative amount of the liberated drug [mg]
A= Diffusion area [cm²]
C0= Starting concentration of the drug in the donor [mg/cm³]
CS= Saturation concentration of the drug in the donor [mg/cm³]
t= Time [s]
Ds= Diffusion coefficient (Liberation coefficient) of the drug [cm²/s]
A plot of Q/A versus square root of t should be linear; the diffusion coefficient is
calculated from the slope.
In case of suspension bases following assumptions must be taken in consideration,
to verify the equation 2.2.:
a) The suspended drug is in a fine state such that the particles are much smaller in
diameter than the thickness of the applied layer.
b) The amount of drug present per unit volume in the donor is substantially greater
than Cs.
c) Drug solubility in the receptor must be fast enough i.e. the dissolution rate should
not be the rate-limiting step.
d) The receptor medium constitutes a perfect sink for the released drug i.e. the
concentration of the drug in the receptor does not exceed 10% of its saturation
concentration throughout the experiment.
e) After the lag-phase the diffusion rate changes only slightly.
f) The concentration gradient at the interface base/membrane is almost linear.
g) Only one drug diffuses through the base.
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2.5. Factors affecting drug release
Drug release from semisolid preparations is known to be affected by a great number
of factors, which can be summarized as follows:
x Cream base: The structure, the type as well as the composition of the cream base
have a direct influence on drug release as all these factors influence the diffusion,
distribution and solubility of the drug in the base (Poulsen et. al., 1968; Benninger,
1977).
x Thickness of cream base layer: The thickness of the base layer reflects the
amount of drug applied. Therefore, increasing the thickness is accompanied by an
increase in the diffused amount of drug (Horsch et al. 1974 b). However, if the
thickness exceeds a certain limit the dose of the drug becomes infinite having
thereby no more influence on drug release.
x Viscosity of cream base: The lower the viscosity of the preparation the easier for
the drug to diffuse through the base to the interface (Korbar et al., 1982; Hsu et
al., 1994; Fang et al., 1996)
x Volume and agitation of receptor medium: The drug liberation is increased by
increased concentration gradient at the interface between donor and acceptor.
This increase of the concentration gradient can be achieved through increasing
the volume of the acceptor, shortening the sampling time (Horsch et al., 1974 b)
or accelerating the speed of agitation of the acceptor. However, it should be taken
in consideration that a high speed of agitation could disturb the uniform contact
between the receptor medium and the membrane whereas a very slow circulation
may result in increasing the thickness of the diffusion layer. An agitation of 400
rpm in the diffusion cell setup is recommended to achieve homogeneous and
rapid mixing (Shah et al., 1999).
x Type of receptor medium: In most cases receptor medium is either water or
physiological buffer system. However, for products containing water-insoluble
drugs, selection of an appropriate receptor medium to maintain sink conditions
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during in vitro release studies is a challenge. In order to achieve or improve drug
release from such topical preparations, receptor media containing surfactants or
different organic/aqueous solvents can be used (Shah et al., 1999).
x pH of acceptor medium: It affects the release of weak electrolytes. Changing the
pH-value influences the partition coefficient of the drug and subsequently its
liberation (Horsch et al., 1974 b).
x Temperature of experiment: Changing the temperature of the experiment has an
influence on the consistency of the base as well as the solubility and diffusion
coefficient of the drug. The experiments are normally carried out at 37°C which is
the body temperature or at 32°C which represents the temperature of the skin
(Horsch et al., 1974 a).
x Dispersion of the drug: The dissolution rate of drugs increases with increased
dispersion. This relation is important for sparingly soluble drugs and has no
significance with increased solubility of the drug in the base (Horsch et al, 1975).
x Solubility of the drug in the base: In suspension-type vehicles drug release is
directly proportional to the amount of dissolved drug in the vehicle (Horsch et al.,
1972).
x Drug concentration in the base: According to the equation of Higuchi (1967) the
liberated amount of drug is directly proportional to the square root of the drug
concentration in the base.
x Particle size: Particle size of the drug is inversely proportional to the dissolution
rate and release, i.e. the smaller the size of particle the greater its rate of solubility
in the base and subsequently its release (Loth et al., 1984).
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2.6. Hazards of dilution of topical corticosteroid preparations
Extemporaneous dilution of topical corticosteroids formulations are used to be very
commonly done in response of physicians’ requests. The rational is that dilution
enables the physician to restrict prescribing to well known corticosteroid molecules,
while at the same time tailoring the formulation to the patients’ need (Gao and Li Wan
Po, 1994). Various authors have drawn attention to the dangers associated with this
practice (Busse, 1978; Mooney, 1974; Smith, 1982).
The dangers of dilution stem from pharmaceutical, bacteriological and
biopharmaceutical considerations.
Pharmaceutical considerations
These are mainly questions of physical compatibility of the product with the diluent
and possible deleterious effects of the diluent on the active ingredient. The “External
diluent directory “ lists some of these incompatibilities (Busse, 1978):
x The FAPG (fatty alcohol propylene glycol) base will easily crack with many cream
and ointment diluents, especially pastes or stiff ointments e.g. zinc ointment.
Problems of drug stability can also occur.
x If betamethasone valerate cream is diluted with a cream base that has a neutral
to alkaline pH, conversion of the 17-ester to the less active 21-ester may occur.
x The dilution of fluocinolone acetonide preparations with an unsuitable vehicle e.g.
those containing oxidising agents, could cause chemical degradation of
fluocinolone acetonide to less active compounds.
These are only a few of the pharmaceutical problems that can arise from dilution of
topical steroid preparations. Another example reported in a previous investigation
showed a larvated incompatibility upon diluting Topisolon ointment with Unguentum
Cordes, both having different types of emulsifiers. Macroscopically, the formulation
appeared homogeneous, however microscopical examination revealed large water
drops indicating coalescence of the emulsion (Wolf, 1988).
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Bacteriological considerations
During dilution of topical steroid preparations, pathogenic bacteria may be introduced
and could infect the diseased skin to which the preparation is applied. That could be
especially hazardous to the patient because there is ample clinical evidence that
steroids help the spread of infection. An organism of major importance in that
respect, particularly in hospital environment, is Pseudomonas aeruginosa, which is
resistant to most antibiotics. It can survive and multiply outside the human body and
cause skin lesions. In 1966 an epidemic strain of Pseudomonas was isolated from
skin lesions of patients to whom a diluted steroid had been applied. Pseudomonas
aeruginosa was found in the diluted cream (Busse, 1978).
Furthermore, on dilution the preservatives may be inactivated due to an
incompatibility or simply by being diluted out to below their effective levels. Many of
the preservatives commonly used in pharmaceutical emulsions are absorbed or
bound by non-ionic emulsifiers and this bound preservative is devoid of antimicrobial
activity.
An additional factor is the partition coefficient of the preservative. The degree of
preservation depends on the availability of the preservative in the aqueous phase. If,
on dilution of a well preserved cream, further oils are added, the preservative may
tend to partition into that oil phase leaving the product in a badly preserved state
(Mooney, 1974).
Thus, for complete microbiological safety, topical preparations would need to be
diluted under aseptic conditions with sterile diluent, which would be both inconvenient
and very costly.
Biopharmaceutical considerations
Marketed formulations of topical corticosteroids result from extensive research of the
optimum concentration and most suitable base for therapeutic effect. The release of
steroid from a topical preparation is dependent on the nature of the vehicle and
therefore dilution with an inappropriate base can lead to the wrong conditions for
adequate release. Moreover, diluting a corticosteroid preparation containing an
antimicrobial agent will most likely reduce it to below its effective concentration. Apart
from the therapeutic disadvantage, in the case of antibiotics this could encourage the
development of resistant organisms (Busse, 1978).
2. Theoretical part 15
The only significant argument in favour of diluting potent proprietary preparations is
that if they are to be used in large quantities by the patient and if the diluted
preparation is shown to be equivalent to the undiluted product in terms of clinical
efficacy then the danger of adverse reactions may be lessened by using the diluted
preparation. Even in this latter situation, however, an adequate knowledge of the
potency likely to result from dilution would normally lead one to be able to select an
undiluted proprietary product of appropriate strength.
Furthermore, as the clinical efficacy of topical corticosteroids is, in most cases,
paralleled by their ability to produce local side effects a degree of dilution which
results in similar clinical efficacy may well not reduce this problem. Moreover, it
should not be too readily assumed that dilution always leads to a smaller risk of
significant systemic absorption and systemic side-effects (Gibson et al, 1983).
Dilution will, however, continue despite these comments; therefore, regulations and
precautions must be put down to control these dilutions in order to protect the
interests of both the prescriber and the patient. Some suggestions were made by
Mooney (1974):
1. Use simple, adequately preserved diluents
2. Make small batches
3. Do not keep longer than necessary for patient treatment
4. Use aseptic techniques for mixing
2.7. The structure of the skin
Skin is essentially composed of two major layers: an outer, unvascularized epithelial
layer (the epidermis), and an inner vascularized layer (the dermis).
Stratum corneum
The stratum corneum constitutes the superfacial layer of the epidermis. It is the final
stage of differentiation and is formed from several layers (10-25) of dead cells
embedded in a lipid matrix. The stratum corneum is about 10 µm thick in the non-
hydrated state. In hand palms and foot soles the stratum corneum is much thicker,
about 400-600 µm (Barry, 1983).
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On a dry weight basis, the stratum corneum is mostly protein (75-80%) with the
greater part being fibrous intracorneocyte D-keratin having a small fraction of
amorphous E-keratin (Matoltsy et al., 1968). Together, these components make the
corneocyte dense and almost impermeable for solutes. Approximately 10-15% of the
protein fraction is water soluble. The remainder of the stratum corneum consists of a
complex lipoidal mixture (5-15%) and unidentified material (5-10%) (Suhonen et al.,
1999).
The viable epidermis
Situated beneath the stratum corneum is the remainder of the epidermis, the viable
epidermis. It ranges in thickness from 75-150 µm and consists of various layers,
characterized by various stages of differentiation. When going inwards, the
penetrating chemical successively crosses the stratum lucidum, the stratum
granulosum (or granular layer), the stratum spinosum (or spinous layer) and the
stratum basale (or basal layer).
In the basal layer, the cells continuously undergo mitoses to renew the epidermis and
in healthy skin, this proliferation compensates the desquamation of dead horny cells
from the skin surface.
The cellular structure of the viable epidermis is predominantly hydrophilic throughout
its various layers and substances can be transported in its intercellular fluids.
Especially for polar substances, the resistance to permeation is considerably lower
than in the stratum corneum (Schaefer et al., 1982).
Dermis
Chemicals finally reach the dermis, a 3-5 mm thick layer, which contains a rich supply
of capillaries, nerves, sweat glands, sebaceous glands, and hair follicles that are
supported by connective tissue (Barry, 1983).
Apart from some radial transport in the dermis by the capillaries of the cutaneous
microvasculature, chemicals are readily absorbed into the blood stream and diluted
systemically. The blood stream enables the dermis to act as a sink for molecules that
finally reach this layer. This ensures a maximal concentration gradient of the
penetrant across the epidermis.
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Fig. 2.2. A cross sectional view of human skin (Gurny and Teubner, 1993)
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2.8. Topical application of drugs
Topical application of drugs for systemic therapy (Wiechers, 1989) may have several
advantages over the conventional oral route.
- It circumvents variables that may influence the gastro-intestinal absorption, such as
the drastic changes in pH along the gastrointestinal tract, food intake, intestinal
motility, etc. Additionally it may eliminate systemic first-pass metabolism as it
circumvents the liver. Moreover, delivering drugs by the transdermal route may
provide controlled, constant administration of the drug allowing continuous input of
drugs with short biological half-lives.
Transdermal therapy, however, also has its limitations. Firstly, and foremost, the skin
acts as a barrier in two directions, controlling the loss of water, electrolytes, and other
body constituents, while preventing the entry of drug molecules as well as harmful or
unwanted molecules from the external environment. Secondly, there may be
pharmacodynamic, physiological and/or physico-chemical limitations. Compounds
may act as irritants (sodium lauryl sulfate); may cause allergic sensitization (some
antibiotics), hyperpigmentation (bliomycin), or be keratolytic (salicylates).
Percutaneous absorption is the uptake of a compound into the systemic circulation
after dermal application. It can be divided into three steps:
x Penetration, which is the entry of a substance into a particular layer or organ
x Permeation, which is the penetration through one layer into another which is both
functionally and structurally different from the first layer.
x Absorption, which is the uptake of a substance into the vascular system (lymph
and/or blood vessel), which acts as the central compartment.
Factors that influence the percutaneous absorption of chemicals through the skin are:
x The structure of the skin
x The physico-chemical characteristics of the penetrant
x The physico-chemical characteristics of the vehicle in which the penetrant is
dosed
x The dosing conditions
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Fig. 2.3. Some stages in percutaneous absorption from a suspension base (Barry,
             1983)
The Fig. 2.3. represents a simple idealization of the drug flux which may arise
clinically following the application of topical suspension vehicles. The drug particles
must first dissolve so that molecules may diffuse within the vehicle to reach the
vehicle-stratum corneum interface. For the drug to move through the skin it must
partition into the stratum corneum and diffuse within this very impermeable barrier.
Some drugs may bind at a so called depot site; the remainder diffuses in the horny
layer, meets a second interfacial barrier and partitions into the viable epidermis.
Whereas the initial partition process may have favoured an increased flux (for
lipophilic drugs), the second partitioning will be unfavourable as the viable epidermis
provides a more hydrophilic milieu compared with the stratum corneum. Any
substance with a high affinity for the horny layer and a very low water solubility may
not be absorbed percutaneously even though it may have penetrated the barrier
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layer. The drug then partitions into the dermis. Within the dermis, additional depot
regions and metabolic sites may intervene in the progress of the drug to a blood
capillary. A fraction of the diffusant may also partition into the subcutaneous fat to
form a further depot (Barry, 1983).
2.9. The stratum corneum barrier function
The barrier function of the skin is firmly attributed to the stratum corneum. The
stratum corneum has a water permeability approximately 1000 times lower than most
other biological membranes, which has been attributed to the unique lipid
composition and content of the stratum corneum and, especially, the exceptional
structural arrangement of the intercellular lipid matrix and the envelope surrounding
the corneocytes (Potts and Francoeur, 1991).
The essential role of the stratum corneum lipids in barrier properties has been
demonstrated by removal of lipids with solvent extraction, which leads to increased
transepidermal water loss and enhanced skin permeability (Sweeney and Downing,
1970). In addition, it has been found that impaired barrier function in diseased skin is
related to abnormalities in stratum corneum lipid composition (Imokawa et al., 1991)
and that the recovery of the barrier function can be achieved by topical application of
stratum corneum lipids. The stratum corneum water permeability has been shown to
be directly correlated with lipid alkyl chain conformation (Golden et al., 1987 b).
2.10. Stratum corneum lipid composition
The lipid composition of the stratum corneum is highly unique. It is virtually devoid of
phospholipids, unlike other biological membranes, and is mostly composed of
ceramides (41%), cholesterol (27%), cholesteryl esters (10%) and fatty acids (9%)
with a small fraction of cholesterol sulfate (2%) (Wertz and Downing, 1989). The lipid
composition and content vary with body site. A structurally heterogeneous group of
seven different ceramides represents the major polar lipids present in the stratum
corneum. This high content of ceramides, having long, straight, saturated aliphatic
chains would seem ideally suited for the formation of highly ordered, impermeable
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membranes, which provide resistance to temperature variations, UV-exposure, and
air oxidation (Schurer and Elias, 1991).
2.11. Stratum corneum lipid arrangement and phase behaviour
The extracellular lipids between the corneocytes are arranged in multiple lamellar
structures forming continuous lipid phases that occupy approximately 20% of the total
stratum corneum volume (Elias and Leventhal, 1979). The lamellar arrangement is
mainly due to the ceramides, which may provide the polar moieties required for such
arrangements and are capable for extensive hydrogen bonding. In addition, it has
been suggested that sufficient amphiphatic material exists in the stratum corneum
lipid fraction such as cholesterol sulfate that maintains the lamellar form (Williams
and Elias, 1987). The lamellae form oriented structures aligned parallel to the surface
of the stratum corneum (Garson et al., 1991).
Given the considerable chain-length diversity among stratum corneum lipids and, on
the other hand, the mechanical properties required of the bilayers, a domain mosaic
model was recently proposed involving segregation of lipids as domains of
crystalline/gel phase lipids bordered by lipids in a liquid crystalline phase provided by
relatively short chain lipids (Forslind, 1994).
2.12. Drug permeation routes
The absorption of the drug through the skin is believed to be passive (Scheuplein
and Blank, 1971). Transdermal permeation can involve passage of molecules across
the intact epidermis or through a shunt pathway offered by the relatively universally
distributed hair follicles and eccrine glands. The latter route is considered to be of
minor importance because these skin appendages actually occupy only 0.1% of the
total human skin surface. In addition, they exercise some influence on percutaneous
absorption due to their secretions which affect the lipid and the water content of the
stratum corneum and so can modify the absorption of molecules (Hueber et al.,
1992). Therefore, it is now widely believed that the transepidermal pathway of
passive diffusion is the principal pathway associated with the permeation of drugs
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through the skin. But for molecules, due to their large molecular size, for example,
the shunt pathway can be significant (Hueber et al, 1994).
Percutaneous absorption via the transepidermal pathway involves diffusion through
the stratum corneum and the viable cell layers of epidermis, and finally through the
upper layers of dermis into the microcirculation (Squier et al., 1991). The rate
determining step in the percutaneous absorption of most drugs is their permeation
across the stratum corneum providing the major portion of resistance (Scheuplein
and Blank, 1971). Only for very lipophilic drugs the essential aqueous nature of the
viable epidermis may provide a significant barrier.
The stratum corneum is often characterized as a brick wall-like structure with the
corneocytes (protein) forming the bricks and the intercellular lipid as a mortar (Elias,
1983). The protein phase is discontinuous while the lipid phase is continuous.
Through the stratum corneum, in theory, there exist two potential pathways; the
transcellular (across the corneocytes and the lipid matrix) and the intercellular (via
the lipid domains between the corneocytes).
However for both routes the structure of the stratum corneum dictates that the
permeants must diffuse across the intercellular lipid layers. The intercellular route is
widely believed to provide the principal pathway for the permeation of most drugs.
Experimental studies have shown that the permeation of most compounds is strongly
dependent on their lipophilicity and molecular size (Guy and Hadgraft, 1988).
However, it has been suggested that only very hydrophilic compounds penetrate
through both the hydrophilic regions of the corneocytes (presumably water
associated with keratin) and the lipid matrix (Flyn, 1989).
Fig. 2.4. A scheme representing suggested routes for drug permeation in the stratum
corneum (i.e., (i) across the corneocytes and the intercellular lipid matrix (the
transcellular pathway) and (ii) via the lipid matrix between the corneocytes (the
intercellular pathway). (Barry, 1987 a)
Intercellular route Transcellular route
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The amount of drug permeated through the skin per unit time and unit area is defined
as the drug-flux J. In the case of perfect sink the flux is calculated after the equation
2.5. (Flynn et al., 1974) which is based on Fick’s 1. law for drug diffusion (equation
2.4.).
dx
dcDq
dt
dm
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Mass flow
J = Drug-flux [g/cm²*s]
A = Permeation area [cm²]
Ds = Apparent diffusion coefficient in the skin [cm²/s]
C0 = Starting concentration of the drug in the donor [g/cm³]
K = Partition coefficient skin/ donor
h = effective skin thickness [cm]
The partition coefficient as well as the effective skin thickness are difficult to be
determined; therefore, they are summarized together with the apparent diffusion
coefficient to the permeability coefficient [cm/s] in equation 2.6..
h
KDP
s 
 Eq. 2.6.
Equation 2.5. is thus simplified to 2.7. :
0CPJ  Eq. 2.7.
-
In suspension vehicles only the dissolved part of the drug is able to diffuse through
the skin; therefore it seemed important to calculate another coefficient that makes a
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relation between the flux and saturation concentration of the drug in the vehicle. This
coefficient is called per-sol-coefficient Z [cm/s] and is calculated as illustrated in
equation 2.8.
sC
JZ  Eq. 2.8.
2.13. Testing of percutaneous absorption
In vitro methods
x
 
Excised stratum corneum: Stratum corneum is the principal barrier of the skin for
penetration of most drugs; therefore, it is suitable for testing the percutaneous
absorption. Besides, the stratum corneum being a dead tissue, enables its
storage after isolation for several months without being affected, thus makes it
possible to test various compounds over a long period using the stratum corneum
of the same donor.
x
 
Excised skin: Using the whole skin is beneficial in testing very lipophilic drugs for
which the aqueous epidermis and dermal layers may provide the significant
hindrance for diffusion (Barry, 1987 a). Furthermore, the excised skin may be also
useful to test the percutaneous absorption of compounds, which are mainly
metabolised in the skin. However, excised skin must be used directly after
preparation in order to maintain the viability and enzymatic activity of the tissue,
which may be regarded as a limitation of this method.
x
 
Stratum corneum lipid model: The impermeability of the stratum corneum to most
drugs is mainly attributed to its unique lipid composition; therefore reconstructing
this lipid composition in the same proportions as in the stratum corneum could be
successfully used to test the percutaneous absorption (Glombitza, 2000). This
method has the advantage that it overcomes the difficulties in obtaining and
preparing the skin or stratum corneum; moreover, it overcomes the interindividual
variations of the donors (age, sex, skin region etc.).
2. Theoretical part 25
x
 
Cell cultured skin: Another alternative to standardize the percutaneous absorption
testing and to overcome the interindividual variations is to construct a model of
the human skin by using cell culture. Using human keratinocytes and fibroblasts it
was possible to culture an artificial human skin that has comparable permeation
properties to excised human stratum corneum (Specht, 1999); furthermore, it is
again useful in testing the permeability of drugs that are principally metabolized in
the viable epidermis.
In vivo methods
x
 
Systemic bioavailability: Percutaneous absorption in vivo is usually determined by
an indirect method based on the measurement of radioactivity in excreta following
topical application of a labeled compound. The usage of radioactive compounds
(usually carbon-14- or tritium labeled) is necessary in human studies because the
plasma levels of the compound are extremely low following topical application
often below assay detection level (Wester et al., 1983). However this method is
only suitable to detect the systemic effect of a topically applied compound and not
a local one.
x
 
Stripping method: The stripping method determines the concentration of a
chemical in the stratum corneum at the end of a short application period (30
minutes). The stratum corneum is removed by successive tape application, the
tape strippings are then assayed for chemical content. Rougier et al. (1987) have
established a linear relationship between this stratum corneum reservoir content
and percutaneous absorption using the standard urinary excretion method.
x
 
Biological response: Another approach used to determine in vivo percutaneous
absorption is to use a biological/pharmacological response. This method is
principally applied for compounds which elicit an easily measurable response. An
example of biological response would be the vasoconstrictor assay of
corticosteroids. This assay uses the skin blanching effect of the corticosteroids to
estimate the rate and extent of drug diffusion to the dermal vasculature, the
intensity of this whiteness correlates directly with the topical availability of the drug
(Mc Kenzie and Stoughton, 1962).
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2.14. Mode of action of penetration enhancers in human skin
A major problem in attempting to control the drug flux arises from the impermeability
of human skin and its biological activity. It would be very useful to circumvent these
problems by including in the formulation molecules which would reversibly remove
the barrier resistance of the stratum corneum and thus allow the drug to penetrate to
the viable tissues and enter the systemic circulation. Such entities are known as
penetration enhancers.
Interactions between penetration enhancer and the lipid bilayer structure can occur at
three places as illustrated in Figure 2.5., i.e. at the polar head groups of the lipid
bilayer (site A), within the aqueous regions between the polar lipid head groups (site
B) and between the hydrophobic tails of the bilayer (site C) (Barry, 1987 b).
Fig. 2.5. Postulated sites of action for penetration enhancers in the intercellular
domain, illustrating the change from relative order to relative disorder after the
insertion of penetration enhancers. Small circles represent polar enhancers such as
propylene glycol and ethanol; linear chain molecules represent Azone and oleic acid
molecules (Barry, 1987 b).
Water and dimethyl sulfoxide are examples of compounds that interact with the polar
head groups of the lipid bilayer (site A). The presence of water molecules results in
hydration shells around the polar head groups via hydrogen bonding. The hydration
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spheres of the lipids will then be disturbed which loosens its packing. This results in a
more fluid and more permeable hydrophobic route (Bennet and Barry, 1985).
Penetration enhancers such as propylene glycol and ethanol exert a direct influence
on the aqueous regions between the polar lipid head groups of the bilayer (site B).
These enhancers penetrate into this region of the tissue in such amounts that they
alter the solubilizing ability of this site; thereby promoting drug partitioning into the
skin which subsequently results in an increased flux of penetrant (Bennet and Barry,
1985).
On the other hand, penetration enhancers like Azone and unsaturated long chain
fatty acids such as oleic acid exert their action on the hydrophobic tails of the bilayer
(site C) by upsetting their packing and increasing their fluidity, thus permitting easier
diffusion of penetrants. Concomitantly, these alterations in the lipid packing may also
affect the rigidity of the polar head group region (Goodman and Barry, 1986).
The key to alter the transcellular route, i.e. the polar pathway, will be to swell the
protein matrix or to change its structure. Such processes are to take place within the
corneocytes at the keratin fibrils and their associated water molecules by interaction
with polar groups, relaxation of binding forces and alteration in the conformation of
the helices, but the enhancer may also interact with whatever lipid remains in the
corneocyte. Extensive interaction may even result in pore routes. Examples of
penetration enhancers acting on polar pathway include pyrolidones and surfactants
(Bennet and Barry, 1985).
2.15. Microstructure of stratum corneum
The barrier properties of the stratum corneum are attributed mainly to its very
complex lipid composition which is characterized by having a high degree of order
and high density which explains the low diffusion coefficient in this medium (Loth,
1989). In order to relate the barrier function to stratum corneum structure the
investigation of the structure of stratum corneum by means of several techniques like
differential scanning calorimetry (DSC), small and wide angle X-ray diffraction (SAXD
& WAXD), electron spin resonance (ESR) or Fourier transform infrared spectroscopy
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(FTIR) seemed to be very important. Thus any alterations in the permeability of the
stratum corneum could be then referred to possible structural changes.
2.15.1. Differential scanning calorimetry (DSC)
Four transitions are observed in the DSC thermal profile of human stratum corneum
between 25-105°C. The transitions occur near 35, 65, 80 and 105°C (Van Duzee,
1975; Golden et al., 1987 b; Hiroven et al., 1994).
The highest temperature transition near 105°C (T4) is due to the thermal
denaturation of intracellular keratin. This peak is not thermally reversible as expected
for a protein denaturation. Furthermore, it is present following solvent treatment of the
stratum corneum, a process known to remove intercellular lipids with little or no
extraction of highly cross-linked keratin. Finally, this transition is absent from a
corneocyte membrane preparation, which is lacking intracellular keratin due to
exhaustive alkali extraction.
The third temperature peak near 80°C (T3) exhibits thermal properties characteristic
to both proteins and lipids. First, this transition is not thermally reversible which is an
indication for the presence of protein. Nevertheless, the Tm decreases to a limiting
value with increasing water content, a behaviour characteristic of numerous water-
lipid systems. In addition, treatment of the sample with lipid solvents removes the
transition from the thermal profile, proving lipid contribution to the peak. It is quite
possible that this peak results from a thermal transition of a corneocyte membrane
protein-intercellular lipid complex. According to this model, the intercellular lipids near
the membrane boundary are stabilized by nearby proteins.
The second temperature peak near 65°C (T2) is due to thermal transitions in the
intercellular lipids. This consideration is ensured by the thermal reversibility of the
transition. Furthermore, increasing water content results in a decrease in the
transition temperature to a limiting value. In addition, the peak is present in a
corneocyte membrane preparation and hence not associated with intracellular
keratin. Finally, the peak is absent in chloroform-methanol-treated samples, a
technique known to extract intercellular lipids (Golden et al., 1987 b).
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The 35°C thermal transition (T1) is small and its occurrence was found to vary from
sample to sample. This peak is always thermally reversible and thus appears lipid in
nature. The small and variable nature of this peak suggests that the lipid is not tightly
associated with the stratum corneum and may arise from sebaceous lipids still
adhering to the surface after hexane washing (Golden et al., 1986).
Fig. 2.6. Thermogram of human stratum corneum (Bouwstra et al., 1993)
2.15.2. Wide-angle X-ray diffraction (WAXD)
WAXD investigations of human stratum corneum reveal two very strong reflection
rings at 0.378 and 0.417 nm, which are probably due to crystalline lipids (Small,
1986). These two reflections are characteristically produced by crystalline lipids with
an orthorhombic perpendicular alkyl chain backing arrangement (Bouwstra et al.,
1992). However, the reflection at 0.417 nm is also characteristic of gel phase lipids
with a slightly looser hexagonal alkyl-chain packing arrangement. It is possible,
therefore, that both crystalline and gel phase lipids may coexist in the stratum
corneum, i.e. there may be lateral phase separation in the bilayers (Cornwell et al.,
1994).
It was noticed that after lipid extraction the reflection at 0.417 exists though of very
low intensity, which was referred to the linkage of these lipids to the corneocyte
envelope (Bouwstra et al., 1992).
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Two broad diffraction rings at 0.46 and 0.98 nm are also observed. The reflection ring
at 0.46 nm is probably due both to an orientational order of hydrocarbon chains in the
liquid state and to soft keratin located in the corneocytes. The reflection ring at 0.98
nm is referred only to soft keratin. The broad non-uniform band indicates a slight
orientation (Bouwstra et al., 1992).
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3. Materials and methods
3.1. Materials
3.1.1. Cream base ingredients
The following materials were used to prepare the bases investigated in this study. All
substances were used from only one batch to exclude the influence of any batch
variations.
x Emulsifying cetostearyl alcohol (Henkel, D-Düsseldorf)
It consists of 10% (m/m) sodium cetostearyl alcohol sulfate and 90% cetostearyl
alcohol. The content of sodium cetostearyl alcohol sulfate in the utilized charge
was 9.9%. The hydroxyl number was 203.
x Cetostearyl alcohol (Caesar & Loretz GmbH, D-Hilden)
The used batch obeyed the instructions of DAB 9 for properties and purity.
x White petrolatum (Hansen & Rosenthal, D-Hamburg)
The congealing point was 54.5°C
x Liquid paraffin DAB 10 (Mainland, D-Frankfurt)
The density was 0.865 (g/cm³)
x Wool fat alcohol (Caesar & Loretz GmbH, D-Hilden)
x Glycerol 85% (Henry Lamotte GmbH, D-Bremen)
x Tween 60 (ICI, UK-Cleveland)
x Isopropyl myristate (Merck, D-München)
The density was 0.853 g/cm³.
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3.1.2. Water
Water was used in bidistilled quality.
3.1.3. Active Ingredient
Micronized hydrocortisone (Synopharm, D-Hamburg) was used in Pharmacopoea
quality (DAB 10). The content determined per HPLC by Synopharm was > 99%.
Structure and further informations are given in 2.1.
3.1.4. HPLC-Mobile phase
Methanol in HPLC quality from the companies Fluke (D-Neu-Ulm) and J.T. Baker
(NL-Deventer) was used.
3.1.5. Buffer
The phosphate buffer pH 7.4 was prepared in accordance to phosphate buffer
solution pH 7.4 containing sodium chloride DAB 1997. However, sodium chloride was
found to disturb the HPLC analysis therefore the buffer was prepared without adding
sodium chloride i.e. 2.38 g sodium monohydrogen phosphate (Merck, D-Darmstadt)
and 0.19 g potassium dihydrogen phosphate (Merck, D-Darmstadt) were dissolved in
one litre bidistilled water. The pH-value of the buffer was adjusted to 7.4 by adding
potassium dihydrogen phosphate.
3.1.6. Commercial products
Soventol® Hydrocortison Creme and its placebo (Knoll Deutschland GmbH, D-
Mannheim)
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3.2 Methods
3.2.1. High performance liquid chromatography (HPLC)
The HPLC system consisted of a gradient pump Beckman System Gold Solvent
Delivery system 126 (Beckman, D-München) and a UV-Detector Beckman System
Gold Detector Module 166 (Beckman, D-München).
The peak identification and analysis were performed by the Beckman Gold
Chromatography Software Version 6.01 (Beckman, D-München).
A reversed phase column (250 x 4 mm) was used, it was filled with Hypersil ODS 5
µm (Grom, D-Herrenberg).
The mobile phase was methanol/water in the ratio 60:40 with a flow rate of 1.1 ml/min
(Way and Hadgraft, 1991). The resulting pressure was 280-290 bar.
The retention time for hydrocortisone was 4.8 minutes at a wave length of 250 nm.
Linear correlation between peak area and hydrocortisone concentrations was
obtained within the concentration range of 0.1 µg/ml-20 µg/ml. The correlation
coefficient was > 0.999.
3.2.2. Differential scanning calorimetry (DSC)
Human stratum corneum as well as the cream bases were thermally analyzed using
a Differential Scanning Calorimeter DSC 220 C with a disc station 5200 H (Seiko, J-
Tokyo). Stratum corneum pieces were folded in an aluminium crucible
(SSC000C008, C3 Analysis Technique, D-Baldheim) and fused on cold. The probes
were measured against empty reference crucible in a temperature range of –20°C to
140°C with a heating rate of 5°C/min. The weight of the hydrated stratum corneum
pieces and the cream base probes was about 12 mg and 6 mg respectively.
3. Materials and methods 34
3.2.3. Wide angle X-ray diffraction (WAXD)
Wide angle X-ray measurements of hydrated human stratum corneum were done
using Debeye-Scherrer Camera (circumference 360 mm).
Small pieces of stratum corneum were carefully brought in an x-ray amorphous glass
capillary (d = 0.5 mm) (Glas, D-Berlin) and were measured for about 96 hours.
Settings of the equipment:
X-ray generator PW 1830 (Philips, D-Kassel)
X-ray tube PW 2253/11 (Philips, D-Kassel)
Accelerating voltage 40kV; anode current 40mA
Radiation CuKD, (O = 0.154 nm)
In order to visualize the diffraction rings, the special film material Fuji 100 (Fuji, J-
Tokjo) was blackened.
The diffraction rings were calculated using Bragg’s equation:
nO = 2*d*sinT
O = wave length; d = interlayer spacing; T = angle of diffraction
3.2.4. Determination of saturation concentration of hydrocortisone
3.2.4.1. Determination of saturation concentration of hydrocortisone in buffer
It is very important to determine the saturation concentration of the drug in the
acceptor phase of the release as well as the permeation experiments in order to be
able to ensure sink conditions. Sink condition exists when the diffused amount of the
drug in the acceptor phase (phosphate buffer) does not exceed 10% of its saturation
concentration.
The saturation concentration of hydrocortisone in phosphate buffer was determined
by adding excess hydrocortisone to phosphate buffer. The suspension was stirred
using a magnetic stirrer (300 rpm) over 24 hours at 20°C. Afterwards, the suspension
was filtered through cellulose acetate filter (pore size 0.22 µm, Sartorius, D-
Göttingen). The concentration of the hydrocortisone in the filtrate was then measured
using the UV-210 A Spectrometer (Shimadzu, J-Kyoto) at a wave length of 250 nm.
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Linear correlation between absorption and hydrocortisone concentration was
obtained within the concentration range 2.5 µg/ml-10 µg/ml.
3.2.4.2. Determination of saturation concentration of hydrocortisone in cream
   bases
The base was prepared with a definite concentration of hydrocortisone; after having
been left for 3 days at room temperature the preparation was examined for the
presence of hydrocortisone crystals using a polarizing microscope, Zeiss
Photomicroscope III (Zeiss, D-Oberkochen). If no crystals were detected, higher
concentrations were examined, until crystals could be found. The first concentration
at which crystals could be detected was taken as concentration at saturation (Loth, et
al., 1979).
3.2.5. Determination of density of cream bases
The determination of the density was necessary to convert the concentrations from
w/w into w/v in order to fulfil the requirements of the Higuchi equation. The density of
the different cream bases was determined at room temperature using a Beckman Air
Comparison Pycnometer 930 ( Beckman, D-München). The weight of the probes was
about 10 g.
3.2.6. Determination of the emulsion type of cream bases
3.2.6.1. Colouring method
The emulsion type was determined by sprinkling a lipophilic (Sudan red Merck, D-
Darmstadt) and a hydrophilic colouring agent (Methylene blue Merck, D-Darmstadt)
on the base. The colouring agent colours the corresponding coherent phase.
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3.2.6.2. Conductivity method
The conductivity was measured by a temperature controlled standard conductivity
measuring cell Tetra Con 96 (Wissenschaftliche Technische Werkstätten WTW, D-
Weilheim) with a microprocessor conductivity meter (WTW, D-Weilheim).
3.2.7. Determination of pH-value
The pH-value of the buffer solution was measured by a pH-meter pH 539
(Wissenschaftliche Technische Werkstätten WTW, D-Weilheim). The calibration was
done by standard buffer solutions pH 4.66 and pH 9.00 at room temperature.
3.2.8. Release experiments
The release experiments were performed in modified Franz diffusion cell (Franz,
1975) (Fig. 3.1.)
Fig. 3.1. Modified Franz diffusion cell
magnetic stirring bar
phosphate buffer pH 7.4
250µl-Hamilton-Syringe
water bath at
37 °C
siliconized Spectrapore
membrane
donor
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The experiments were carried out in triplicate. The donor compartment was filled with
the formulation and phosphate buffer pH 7.4 (3.1.5.) was used as acceptor. The
utilized cells had a liberation area ranging from 0.47 to 0.59 cm² and an acceptor
volume varying between 4.4 and 6.5 ml. A proper homogenization of the released
drug in the acceptor throughout the experiment was achieved by a rotating magnet
(400 rpm).
Donor and acceptor were separated from each other by a Spectrapore membrane
MWCO 6000-8000 (Spectrum Medical Industries; USA Los Angeles). In order to
prevent the diffusion of water through the donor phase, the membrane was
impregnated by polymethylsiloxane. This was done by initially hydrating the
membrane in water then soaking it for 2 minutes in a 2% m/m solution of silicone oil
AK 350 (Wacker, D-München) in diethyl ether (Merck, D-Darmstadt). The membrane
was then stretched on the Franz cell and brought in horizontal position to ensure
homogeneous thickness of the silicone film. Finally, 0.5 ml of the silicone oil solution
was applied to the top of the membrane and kept over night under the hood to
evaporate the ether thereby ensuring a final concentration of 1.2 mg silicone polymer
per cm² of liberation area.
The acceptor compartments of the Franz cells were mounted in a water bath at 37°C,
whereby the membranes have a temperature of 32°C which is comparable to the
physiological temperature of the skin surface. The duration of the experiment was 7
hours. Aliquots of 250 µl using a 250 µl-Hamilton-Syringe 1725 RN (Hamilton, CH-
Bonaduz) were taken every 30 minutes in the first 2 hours, then every 60 minutes
and replaced by fresh buffer. The amount of hydrocortisone in the acceptor medium
was analyzed by HPLC (3.2.1.).
3.2.9. Excised human stratum corneum
3.2.9.1. Isolation of stratum corneum
Healthy skin gained in plastic surgeries from the abdominal region of female donors
was ultilized. Immediately following excision the skin was cooled and the
subcutaneous fat tissue was mechanically removed by a scalpel. Afterwards, the skin
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pieces were frozen in liquid nitrogen then stored maximally for 12 months at –25°C,
until used for the experiment.
Prior to the experiment the skin pieces were allowed to thaw gradually to room
temperature and prepared as thin as possible by mechanically removing a part of the
dermis. Stratum corneum sheets were isolated by trypsination (Kligman and
Christophers, 1964). This was done by spreading the skin sheet with its dermal side
on filter paper, which was wetted with 2% aqueous trypsin solution (Pancreas
protease; Merck, D-Darmstadt) and incubated for 24 hours at 37°C. After this time
the stratum corneum was carefully peeled off from the underlying cells using a blunt
forceps. To prevent further enzymatical degradation, the stratum corneum was
bathed for several minutes in a 0.01% aqueous solution of trypsin inhibitor (Type II-O:
Chicken egg white; Sigma, D-Steinheim), then washed several times in water and
subsequently dried and stored at room temperature in a desiccator over silica gel.
In order to prevent any possible changes or degradation of stratum corneum during
storage, the isolated sheets were used within 4 months.
3.2.9.2. Permeation experiments through excised human stratum corneum
Permeation experiments were performed in the Franz cell diffusion cells (Fig. 3.1.).
The same cell sizes regarding the diffusion area and acceptor volume as well as the
same donor and acceptor were used as in the release experiments (3.3.8.). Prior to
experiment the stratum corneum sheets were cut into small pieces, (about 1.5 x 1.5
cm), examined for the absence of holes then completely hydrated in water. Before
mounting the stratum corneum pieces on the diffusion cells the sheets were placed
on polycarbonate filter TMTP, 5 µm (Millipore, D-Eschborn) for higher mechanical
stability.
The experiment was carried out at least in triplicate at 37°C. Samples of 250 µl were
taken from the acceptor compartment over 29 hours and replaced by fresh buffer.
The concentration of hydrocortisone was determined by HPLC as described in 3.2.1.
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3.2.10. Pretreatment of excised stratum corneum for DSC and WAXD
  experiments
In order to obtain sharper transitions and reflections stratum corneum was hydrated
to 20% water content by placing it in an desiccator with saturated sodium chloride
solution (rel. humidity: 75.2% at room temperature) for 48 hrs. Afterwards, stratum
corneum was cut into pieces of about 12 mg which were then immersed in the
respective cream bases for 30 minutes at 37°C.
After this time the rests of the cream bases were removed carefully and the stratum
corneum sheets were pressed between two filter papers until no fat spots were
observed on the filter paper any more.
The stratum corneum sheets were then folded in an aluminium crucible and analyzed
by DSC (3.2.2.) or brought in a glass capillary for WAXD measurements (3.2.3.).
3.2.11. Rheological characterization of cream bases by oscillatory
            measurements
Rheological measurements were performed at 20°C on a controlled stress rheometer
CVO/CS (Bohlin Instruments, D-Mühlacker) equipped with a cone and plate system
CP4/40 having a cone angle of 4° and a diameter of 40 mm. The split between cone
and plate was 150 µm.
Oscillatory measurements were carried out to detect the viscous as well as the
elastic properties of the cream bases without disturbing the structure of the base. The
measured parameters like phase angle, complex viscosity and the moduli were
calculated by software version 5.40.
First, the viscoelastic range for all bases was determined at constant frequency (1Hz)
by driving a shear stress ramp. For almost all bases a shear stress of 35 Pa seemed
very suitable for the oscillatory measurement within the viscoelastic range except for
a few bases (mentioned later) a higher shear stress (100-150 Pa) was chosen as the
measured parameters fluctuated strongly at lower shear stress values.
The measurement was repeated three times for each cream base.
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3.2.12. Preparation of cream bases
The cream bases were prepared manually according to the instructions of the
German Pharmacopoeia, DAB 10. Briefly, the fatty phase was melted at 70°C in a
water bath and stirred to room temperature in the case of the anhydrous bases. In
the case of hydrous vehicles the aqueous phase was also heated to 70°C on a hot
plate and added to the melted fatty phase and then stirred to room temperature. The
evaporated water during preparation was replaced after cooling. The prepared cream
bases were stored at room temperature and used within maximal two weeks.
3.2.13. Preparation of cream base dilutions
The dilutions of cream bases were performed using an Unguator (GAKO Konietzko
GmbH, D-Bamberg). The Unguator (Fig. 3.2.) is defined as a cream base mixer
equipped with specialized Unguator-containers. The cream base could be directly
prepared in the Unguator even on hot (Alberg, 1998) or used like in this case as a
mixer for the already manually prepared bases.
Fig. 3.2. Unguator mixer
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The advantage of the Unguator is the complete homogeneity of the diluted
preparations even the hydrophilic together with the lipophilic ones. The
homogenization was done at room temperature for two minutes at 1000 rpm.
3.2.14. Incorporation of hydrocortisone in the vehicles
Hydrocortisone was incorporated in the already prepared vehicles on cold using the
Unguator. The Unguator was proven for its outstanding homogenization of the drug
in the base (Zobel et al., 1997). Half of the base was weighed in the Unguator-
container, hydrocortisone was added then the container was filled with the rest of the
base until the required weight was achieved. The homogenization was done also for
2 minutes at 1000 rpm.
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4. Results and discussion
4.1. Cream bases
4.1.1 Composition of cream bases
In order to investigate the effect of diluting a topical semisolid formulation with other
cream bases on drug release and permeation through excised human stratum
corneum, water-containing hydrophilic ointment DAB (1998) (WHS) with 1%
hydrocortisone was chosen as a model cream (WHS 1%). Hydrocortisone was
selected as an example for a topically applied corticosteroid because topical
corticosteroid preparations are widely diluted in practice.
WHS 1% was diluted with the same base (WHS) and other bases chosen from the
German Pharmacopoeia, DAB 1998. The vehicles chosen were considered to cover
a wide range of base types regarding the lipophilicity, hydrophilicity and water
content. They can be classified into the following types:
- anhydrous hydrophilic base:
  hydrophilic ointment (HS), Hydrophile Salbe DAB 1998
30% emulsifying cetostearyl alcohol
35% liquid paraffin
35% white petrolatum
- anhydrous lipophilic base:
  wool fat ointment (WS), Wollwachsalkoholsalbe DAB 1998
93.5% white petrolatum
  6.0% wool fat alcohol
  0.5% cetostearyl alcohol
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- water-containing hydrophilic bases:
  water-containing hydrophilic ointment (WHS), Wasserhaltige Hydrophile Salbe DAB
  1998
70% hydrophilic ointment
30% water
  non-ionic hydrophilic cream (NHC), Nichtionische Hydrophile Creme DAB 1998
10% cetostearyl alcohol
25% white petrolatum
  5% tween 60
10% glycerol 85%
50% water
- water-containing lipophilic base:
  water-containing wool fat ointment (WWS), Wasserhaltige Wollwachsalkoholsalbe
  DAB 1998
50% wool fat ointment
50% water
4.1.2. Preparation of the cream bases
All cream bases were prepared according to the instructions of the German
Pharmacopoeia DAB, 1998.
There were two alternatives for the preparation of the dilutions. The first one was the
hot-method, i.e. both bases were melted together then stirred to room temperature.
The other possibility was, to stir both bases together at room temperature using the
Cito Unguator (cold-method). In order to select the suitable method for dilution a
drug release experiment was carried out. The diluted formulations WHS 1%/HS 1:1,
WHS 1%/WHS 1:1 and WHS 1%/WHS 1:2 were prepared by both methods and the
amount of hydrocortisone released after 7 hrs was determined.
As seen in Fig. 4.1. the amount of hydrocortisone released from all formulations
prepared by the cold-method was greater than those prepared by the hot-method.
One interpretation of this finding would suggest that hydrocortisone is partially
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degraded when the bases are melted at a temperature of about 70°C. Besides the
structure of the diluted formulation prepared by the melting method could be
completely different from that prepared by the cold-method. Accordingly,
hydrocortisone may be integrated differently in the structure of the base. The hot-
method is thus not easily standardized as different bases may need different times
for melting.
Fig.4.1. Release experiment of hydrocortisone from WHS/HS 1:1, WHS/WHS 1:2 and
             WHS/WHS 1:1
For the above mentioned reasons and the fact that the dilutions in the practice are
mostly done on cold, the cold-method was selected to prepare all diluted formulations
in this work. The method is described in detail in 3.2.13.
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4.2. Drug release experiments
In order for a drug in a topical formulation to exert its action it must be first released
from the preparation to the surface of the skin. Drug release from semisolid
preparations is known to be vehicle-dependent (Benninger, 1977). Therefore, one of
the most serious incompatibilities that may occur upon diluting a cream preparation
with another base is the unexpected change in drug liberation depending on the type
of base used for dilution. In this chapter the influence of diluting a cream base with
other bases on drug liberation was investigated. Furthermore, the solubility of the
drug in the different bases was determined to detect its possible effect on drug
release. The drug release experiments and drug solubility in the base were
performed as described in 3.2.8. and 3.2.4.2. respectively.
4.2.1. The influence of base type on drug release
As previously mentioned five bases (WHS, WWS, NHC, HS and WS) with different
compositions and properties were chosen from the German Pharmacopoeia, DAB
1998 in order to investigate the influence of base type on drug release.
The cream bases were prepared with 1% hydrocortisone and examined for their drug
release. The amount of drug released per unit area (µg/cm²) was plotted versus the
square root of time (min½).
Fig. 4.2. Release of hydrocortisone from 1% WHS, NHC, WWS, HS and WS
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Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
NHC 1% 8.33 5.75
HS 1% 1.63 0.60
WWS 1% 0.52 0.14
WS 1% 0.58 0.39
Table 4.1. Liberation coefficients calculated from the slopes of the liberation curves of
                 the studied cream bases
A linear correlationship was obtained between the cumulative amount of drug
released in microgram per contact area in square centimetres and the square root of
time. Therefore liberation coefficients could be calculated from the slopes of the
graphs according to Higuchi equation (2.2.) (Table 4.1.).
Figure 4.2. shows that the liberation rates of WHS (70% water) and NHC (50% water)
were very high with no significant difference, followed by HS (anhydrous) with a
remarkably low liberation profile. At last WS (anhydrous) and WWS (50% water)
showed the lowest liberation rates. This result reveals the great influence of water on
drug liberation when incorporated in the hydrophilic bases, while having no effect on
liberation when present in lipophilic vehicles.
The solubility of hydrocortisone in all studied formulations was very limited, which
means that hydrocortisone was rather suspended in the bases than dissolved,
however, only the soluble part of the drug was able to diffuse. Therefore, it was
important to determine the saturation concentration (Cs) of hydrocortisone in the
different bases in order to reveal its possible influence on drug release (Table 4.2.).
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WHS and NHC exhibited the greatest solubilizing capacity for hydrocortisone. The
solubility of hydrocortisone is decreased to some extent in HS, while being relatively
low in WS. These findings indicate that the solubility of hydrocortisone is significantly
reduced in the anhydrous bases. The greater solubility of hydrocortisone in HS
compared to WS may be attributed to the presence of emulsifying alcohols in the
former which are able to solubilize the drug (Horsch et al., 1973; Loth et al., 1979).
The also noticed very low solubility of the drug in WWS reveals the great solubilizing
capacity of the aqueous phase in o/w systems being the external phase whereas
playing no role when incorporated inside the base (w/o-systems).
It is obvious that the release of hydrocortisone from the cream bases studied agrees
well with the solubility of hydrocortisone in these bases. The release of hydrocortisone
thus seems to be dependent on the concentration of dissolved hydrocortisone in the
bases.
Base Cs
[%, w/w]
WHS 0.012
NHC 0.012
HS 0.005
WWS 0.002
WS 0.0012
Table 4.2. Saturation concentration of hydrocortisone in the different cream bases at
                   20qC.
Considering the microstructure of the cream bases (Fig. 4.3 a, b, c and d) in addition
to the solubility of hydrocortisone helps to explain the different liberation profiles.
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Fig. 4.3.a                                                       Fig. 4.3.b
a) mixed crystals of cetostearyl alcohol              a) mixed crystals of non-ionic o/w
   and Na-cetostearyl alcohol sulfate                       emulsifier and cetostearyl alcohol
b) interlamellar fixed water                                  b) interlamellar fixed water
c) cetostearyl alcohol semihydrate                      c) lipophilic gel phase
d) bulk water                                                        d) bulk water
e) lipophilic dispersed phase                               e) lipophilic dispersed phase
Fig. 4.3.c                                                       Fig. 4.3.d
                Paraffin                                               a) water drops, b) excess emulsifier crystals
                Fatty alcohol                                       c) liquid lipophilic phase with dissolved
                Fatty alcohol sulfate                             emulsifier molecules, d) lipophilic gel phase
Fig. 4.3.a, b, c and d: Microstructure of WHS, NHC, HS and WWS respectively
                                   (Niedner and Ziegenmeyer, 1992)
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WHS as well as NHC are o/w systems having similar microstructures. They consist of
4 phases, a hydrophilic gel phase, a lipophilic gel phase, an aqueous bulk phase and
an internal dispersed lipophilic phase (Niedner and Ziegenmeyer, 1992). The high
liberation rates of both creams are probably due to the fast release of hydrocortisone
from the external aqueous phase (Benninger, 1977) and the relatively high solubility
of hydrocortisone in the bases.
HS is a hydrophilic, anhydrous cream base. Cetostearyl alcohol together with sodium
cetostearyl alcohol sulfate build a mixed crystal forming a three-dimensional network
in which paraffin and white petrolatum are immobilized (Niedner and Ziegenmeyer,
1992). The different results for WHS and HS in context with both the liberation and
solubility studies prove the increased solubility of hydrocortisone in the external
aqueous phase.
WS is a lipophilic base consisting mainly of white petrolatum (93.5%), in which the
wool fat alcohols are partly suspended and partly dissolved. In this base the wool fat
alcohols act as lyotropic solubilizing agents (Loth et al., 1979). The solubility of
hydrocortisone in WS is very low, about 10 times lower than that in WHS and NHC
and this agrees well with its low liberation rate.
No significant difference between WWS and WS concerning their liberation profiles
was observed. WWS is a w/o system, the internal phase is the aqueous phase which
is incorporated as droplets inside the system (Niedner and Ziegenmeyer, 1992)
having no significant influence on the diffusion and the solubility of hydrocortisone.
The diffusion through the external, more viscous, oily phase seems to be the rate
limiting step for drug liberation.
Similar results were obtained by Benninger (1977), however, a contradiction is
observed concerning the release of the drug from HS in contrast to WS. The author
reported that the release from WS was significantly greater than from HS.
This contradiction can be referred to the usage of salicylic acid as a model substance
for the liberation study. The author suggested that salicylic acid being not readily
soluble in white petrolatum, is mainly concentrated in the mixed crystals of HS thus
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only the small part dissolved in white petrolatum is ready to diffuse. In WS, the drug is
homogeneously distributed in the base having thereby a greater liberation rate. This
finding indicates that hydrocortisone is acting differently being probably
homogeneously distributed in both vehicles. Moreover, the greater saturation
concentration of hydrocortisone in HS in contrast to WS is considered to be the
reason for its greater release from HS.
4.2.2. Influence of dilution on drug liberation
4.2.2.1. Dilution of WHS 1% with different cream bases
4.2.2.1.1. Dilution of WHS 1% with WHS
WHS with 1% hydrocortisone was diluted with WHS in the ratios 1:1, 1:2 and 1:3. As
long as the same vehicle was used for the dilution the influence of any variations in
structure of the vehicle or in solubility of hydrocortisone is excluded i.e. the dilution
resulted only in the reduction of hydrocortisone concentration in the final preparation
to the half, third and fourth amount, respectively. Therefore, one would predict a
respective decrease in drug liberation.
Fig. 4.4., however, reveals that the dilutions resulted in higher liberation rates than
expected. With the dilution ratio of 1:1 the liberation rate was not reduced to the half
but it was rather higher. The same was noticed with the ratios of 1:2 and 1:3.
The liberation coefficients were again calculated from the slopes of the graphs and
are illustrated in Table 4.3.
These data are in agreement with those of Horsch et al. (1975), who have shown that
the increase in liberation is not proportional to the increase of drug concentration, i.e.
the four times increase of prednisolone concentration in a suspension vehicle resulted
in a raised liberation by the factor of 1.6 only.
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Fig. 4.4. Release of hydrocortisone from 1% WHS diluted 1:1, 1:2 and 1:3 with WHS
Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS 1:1 5.74 5.05
WHS 1:2 4.53 4.76
WHS 1:3 3.29 3.33
Table 4.3. Liberation coefficients calculated from the slopes of the liberation curves of
                 WHS diluted 1:1, 1:2 and 1:3 with WHS
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This observation could be explained by regarding the solubility of hydrocortisone in
WHS (Table 4.2.). It is clear that in WHS 1% as well as in all diluted formulations the
drug is suspended to a great extent, but only the dissolved part of the drug, which
remains unchanged in the diluted formulations, can diffuse. In conclusion, the reason
behind the reduced drug release in the diluted formulations is not the reduced
amount of drug in the bases but probably the variation in concentration gradient
between the suspended and the dissolved drug upon dilution. The concentration
gradient has a direct influence on the dissolution rate of the suspended particles
which supply the base with drug during drug release. The dissolution rate, which is
the rate limiting step decreases with increased distance between the suspended
particles in the base.
4.2.2.1.2. Dilution of WHS 1% with WWS
It was interesting to investigate the effect of diluting a hydrous hydrophilic base with a
hydrous lipophilic one. For this purpose WHS 1% was diluted 1:1, 1:2 and 1:3 with
WWS.
Fig. 4.5. Release of hydrocortisone from WHS 1% diluted 1:1, 1:2 and 1:3 with WWS
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Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS/WWS 1:1 4.18 9.29
WHS/WWS 1:2 0.37 0.15
WHS/WWS 1:3 0.38 0.13
Table 4.4. Liberation coefficients calculated from the slopes of the liberation curves of
                 WHS diluted 1:1, 1:2 and 1:3 with WWS
Diluting WHS 1% with WWS shows an interesting liberation profile. The ratio of 1:1
resulted in a reduction in the liberation rate of WHS 1% almost to the half while the
dilutions 1:2 and 1:3 decreased the release of hydrocortisone drastically (Fig. 4.5.).
Regarding the solubility of hydrocortisone in the different diluted formulations (Table
4.5) reveals that the solubility of hydrocortisone is greatly reduced upon diluting WHS
with WWS in the ratio 1:1 without being significantly affected in further dilutions. Thus
the saturation concentration of hydrocortisone in this case only explains the reduced
release of hydrocortisone generally upon dilution but does not explain the great
difference in hydrocortisone liberation between the 1:1 combination and the other
dilutions.
From Table 4.4. it is obvious that the liberation coefficient of the combination 1:1
possesses a remarkably high value although the slope of this formulation is about the
half of that of WHS 1%. This contradiction is due to the very low solubility of
hydrocortisone in the 1:1 combination in contrast to WHS 1% (Table 4.5). In order to
calculate the liberation coefficient the slope² must be divided by the saturation
concentration according to Higuchi equation (2.4.).
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Base Cs
[%, w/w]
WHS 0.012
WHS/WWS 1:1 0.0033
WHS/WWS 1:2 0.0027
WHS/WWS 1:3 0.0023
Table 4.5. Saturation concentration of hydrocortisone in WHS diluted 1:1, 1:2 and 1:3
                  with WWS
This finding allows the conclusion that the 1:1 combination is probably still an o/w
system, whereas further increasing the amount of WWS in the mixture converts it into
a w/o one. This was proven by conductivity and colouring tests. The combination 1:1
showed a blue colouration with methylene blue and a conductivity of 94 µS/cm. The
combinations 1:2 and 1:3 gave no blue colour with methylene blue but exhibited a
bright red colour with sudan red and a conductivity of just 0.04 µS/cm.
This phenomenon adds a further proof that hydrocortisone is dissolved to a greater
extent in the aqueous phase i.e. in o/w systems, where the aqueous phase is the
external one allowing the fast release of hydrocortisone whereas in w/o systems the
aqueous phase is incorporated inside the base retarding thereby the diffusion of
hydrocortisone.
4.2.2.1.3. Dilution of WHS 1% with WS
WS differs from WWS in being anhydrous. How far the absence of water content in
WS influences the release of hydrocortisone from the diluted formulations is
illustrated in Fig.4.6. and Table 4.6.
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Fig. 4.6. Release of hydrocortisone from WHS 1% diluted 1:1, 1:2 and 1:3 with WS
Diluting WHS 1% with WS resulted in all combinations in very low liberation rates
which indicates, that a phase conversion from the w/o system to the o/w system has
taken place already with the dilution ratio of 1:1. This was proven with a colouring test
using sudan red, which gave a bright red colour for all dilution ratios indicating a
lipophilic external phase.
Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS/WS 1:1 0.48 0.23
WHS/WS 1:2 0.37 0.15
WHS/WS 1:3 0.38 0.13
Table 4.6. Liberation coefficients calculated from the slopes of the liberation curves of
                 WHS diluted 1:1, 1:2 and 1:3 with WS
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It is worthy to note that the liberation coefficients of all dilutions with WS as well as
WWS 1% and the combinations WHS/WWS 1:2 and 1:3 have similar values which
are all significantly lower than WS 1% (Tables 4.1, 4.4. and 4.6). This finding allows
the conclusion that, all these formulations being w/o systems, permit only the part of
the drug which is soluble in the outer fatty base to diffuse whereas the release of
hydrocortisone which is present in the internal aqueous phase is retarded.
The saturation concentration of hydrocortisone is greatly reduced upon dilution as
seen in Table 4.7. Moreover, the 1:2 and 1:3 combinations have identical values
being not significantly different from the 1:1 dilution. These data correlate well with
the release of hydrocortisone from the bases.
Base Cs
[%, w/w]
WHS 0.012
WHS/WS 1:1 0.002
WHS/WS 1:2 0.0015
WHS/WS 1:3 0.0015
Table 4.7. Saturation concentration of hydrocortisone in WHS diluted 1:1, 1:2 and 1:3
                  with WS
4.2.2.1.4. Dilution of WHS 1% with HS
Diluting WHS 1% with HS which has the same composition as WHS, with exception
of being anhydrous, not only reduced the hydrocortisone concentration but it also
decreased the water content. As previously shown, the decrease in hydrocortisone
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concentration does not have a major influence on drug release as long as the drug is
suspended in the vehicle. Thus the factor that is expected to affect drug release is
the amount of the aqueous phase in addition to the type of the system being an o/w
system or a w/o one. To what extent drug liberation from WHS is influenced by the
dilution with HS is demonstrated in Fig. 4.7. and Table 4.8.
From Fig. 4.7. it is obvious that the hydrocortisone liberation was reduced drastically
upon dilution for all formulations. However, the release rate from the dilution 1:1 was
greater than the dilutions 1:2 and 1:3 which were not significantly different. Colouring
and conductivity tests were carried out to identify the type of emulsions of the
resulted dilutions. Both tests showed that the combination 1:1 is still an o/w system,
whereas a phase conversion has taken place for the other two dilutions. This finding
explains the greater liberation coefficient of the 1:1 formulation (Table 4.8.) in
contrast to the others.
Fig. 4.7. Release of hydrocortisone from WHS 1% diluted 1:1, 1:2 and 1:3 with HS
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Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS/HS 1:1 1.43 0.63
WHS/HS 1:2 0.35 0.08
WHS/HS 1:3 0.33 0.09
Table 4.8. Liberation coefficients calculated from the slopes of the liberation curves of
                 WHS diluted 1:1, 1:2 and 1:3 with HS
Nevertheless, the 1:1 dilution, despite of being an o/w system, revealed a
significantly low liberation profile compared to WHS 1% which confirms again that
hydrocortisone is dissolved to a great extent in the external aqueous phase.
Decreasing the amount of aqueous phase by dilution with HS therefore affects the
drug release negatively.
Base Cs
[%, w/w]
WHS 0.012
WHS/HS 1:1 0.0066
WHS/HS 1:2 0.005
WHS/HS 1:3 0.005
Table 4.9. Saturation concentration of hydrocortisone in WHS diluted 1:1, 1:2 and 1:3
                  with HS
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Regarding Table 4.9. it is obvious that the solubility of hydrocortisone in the
formulations – being slightly greater in the 1:1 combination than in the other two
dilutions which have identical values - is in agreement with the above mentioned
conclusion.
However, it seems surprising that HS 1% being anhydrous thus possessing a lower
solubilizing capacity for hydrocortisone has almost the same liberation coefficient as
WHS/HS 1:1 which is an o/w system with greater saturation concentration of
hydrocortisone. An explanation for this finding could be that the decreased
concentration of the drug, and consequently the decreased concentration gradient
between suspended and dissolved drug, in the diluted formulation (WHS/HS 1:1) is
compensated by the increase in hydrocortisone solubility in the base.
4.2.2.1.5. Dilution of WHS 1% with NHC
It was interesting to investigate the effect of using a hydrous hydrophilic base other
than WHS as a diluting vehicle. For this purpose the non-ionic hydrophilic cream,
NHC, was chosen.
Fig. 4.8. Release of hydrocortisone from 1% WHS diluted 1:1, 1:2 and 1:3 with NHC
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From Fig. 4.8. it is to be noticed that the 1:1 dilution reduced the release of
hydrocortisone only to some extent being only slightly greater than further dilutions
(1:2 and 1:3) which have very close liberation rates. The relative high liberation rates
of all formulations is referred to their base type being all o/w systems with high water
content; therefore, hydrocortisone readily diffuses from the external aqueous phase.
Furthermore, the relative good solubility of hydrocortisone in all formulations as
shown in Table 4.11 can be considered as a further explanation for the high liberation
profiles. It is believed that a good solubility of the drug in the vehicle is associated
with a fast release, resulting in a steep concentration gradient in the base with a
great difference between saturation concentration and the concentration of the drug
at the interface through which the molecules continue to diffuse (Loth et al., 1984).
The reduced liberation rates of the dilutions, despite of having all the same amount of
dissolved drug which is equal to that of WHS 1% (Table 4.11.), can only be
interpreted as the variation in concentration gradient between suspended and
dissolved drug upon dilution.
Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS/NHC 1:1 4.86 3.82
WHS/NHC 1:2 3.82 2.99
WHS/NHC 1:3 3.02 2.44
Table 4.10. Liberation coefficients calculated from the slopes of the liberation curves
                   of WHS diluted 1:1, 1:2 and 1:3 with NHC
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It is obvious that diluting WHS 1% with NHC gave similar liberation profiles like those
obtained when WHS 1% was diluted with WHS (Fig. 4.4.). This was expected as both
are o/w systems having a similar four-phase microstructure. Moreover, both bases
have identical dissolving capacity for hydrocortisone as shown in Table 4.11.
Base Cs
[%, w/w]
WHS 0.012
WHS/NHC 1:1 0.012
WHS/NHC 1:2 0.012
WHS/NHC 1:3 0.012
Table 4.11. Saturation concentration of hydrocortisone in WHS diluted 1:1, 1:2 and
                   1:3 with NHC
4.2.2.1.6. Dilution of WHS 1% with white petrolatum
It seemed important to investigate the effect of diluting WHS 1% with white
petrolatum being a main component of all studied bases. White petrolatum is
lipophilic in nature containing no emulsifying components.
From Fig. 4.9. it is obvious that the liberation rate was reduced drastically as a result
of the phase conversion upon dilution. This finding matches with the results obtained
with WHS 1% diluted with other lipophilic bases.
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Fig. 4.9. Release of hydrocortisone from WHS 1% diluted 1:1 with white petrolatum
In order to investigate the effect of adding hydrophilic and lipophilic emulsifiers to
white petrolatum on liberation the release rates of hydrocortisone from the
formulations WHS/HS 1:1 and WHS/WS 1:1 respectively were compared to that of
WHS/white petrolatum 1:1.
Fig. 4.10. Release of hydrocortisone from WHS 1% diluted 1:1 with HS, WS and
                white petrolatum
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Fig 4.10. shows that the formulation WHS/HS 1:1 exhibited the greatest liberation
profile among the three preparations. It was shown previously (4.2.2.1.2.) that this
combination is an o/w system, i.e. the emulsifier maintained the hydrophilic character
of the base. However, the emulsifier is not the only factor influencing the drug release
in this case, as the water content plays also a major role. The presence of 35% water
content in the formulation allowed the hydrophilic emulsifier to retain the hydrophilic
character of the base. In the case of lower water contents a phase conversion to the
w/o type takes place in spite of the presence of the hydrophilic emulsifier.
Furthermore, the emulsifier possesses a solubilizing effect, thus HS has the greatest
solubilizing capacity for hydrocortisone as shown in Table 4.12. It is interesting to
note that the liberation coefficient as well as the drug solubility of WHS/HS 1:1 is
about three times greater than those of WHS/WS 1:1 (Table 4.12 and 4.13).
Base Cs
[%, w/w]
WHS 0.012
WHS/HS 1:1 0.0066
WHS/WS 1:1 0.002
WHS/white petrolatum 1:1 0.0015
Table 4.12. Saturation concentration of hydrocortisone in WHS diluted 1: 1with HS,
                   WS and white petrolatum
The liberation profiles of the formulations WHS/WS 1:1 and WHS/white petrolatum
1:1 were very close i.e. the addition of a lipophilic emulsifier to white petrolatum did
not effectively alter the drug release as seen in Fig. 4.10. However, the increased
hydrocortisone release from WHS/WS 1:1 in contrast to WHS/white petrolatum 1:1 is
suggested to be attributed to the solubilizing effect of the emulsifier to hydrocortisone
(Table 4.13.).
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Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS 1% 8.63 5.72
WHS/HS 1:1 1.43 0.63
WHS/WS 1:1 0.48 0.23
WHS/white petrolatum 1:1 0.21 0.055
Table 4.13. Liberation coefficients calculated from the slopes of the liberation curves
                    of WHS diluted 1:1with HS, WS and white petrolatum
4.2.2.2. Dilution of WWS 1% with different cream bases
It seemed also interesting to incorporate the drug into a lipophilic base and to
investigate the effect on drug release when diluted with the other cream bases. WWS
1% was chosen for this purpose as a model cream. It was diluted in the ratio 1:1 with
WHS, HS and WWS.
Fig. 4.11. reveals that diluting WWS 1% with WHS resulted in a remarkable increase
in drug release, in spite of reducing the amount of drug to the half. This interesting
phenomenon is of course due to the phase conversion to the o/w system upon
dilution, permitting thereby hydrocortisone to diffuse fast from the external aqueous
phase.
Using HS for the dilution showed only a minimal increase in liberation, whereas
diluting WWS 1% with the same base reduced the liberation more than to the half.
The slight increase in liberation upon dilution with HS is referred to the increased
amount of dissolved drug due to the solubilizing effect of the emulsifying mixed
crystals in HS.
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Fig. 4.11. Release of hydrocortisone from WWS 1% diluted 1:1 with WHS, HS and
                WWS
Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WWS 1% 0.52 0.14
WWS/WHS 1:1 4.4 10.27
WWS/HS 1:1 0.57 0.194
WWS/WWS 1:1 0.16 0.022
Table 4.14. Liberation coefficients calculated from the slopes of the liberation curves
                    of WHS diluted 1:1 with HS, WS and white petrolatum
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The decreased release noticed for the formulation WWS/WWS 1:1 can be only
attributed to the reduced concentration gradient between suspended and dissolved
drug.
Base Cs
[%, w/w]
WWS 0.002
WWS/WHS 1:1 0.0033
WWS/HS 1:1 0.003
WWS/WWS 1:1 0.002
Table 4.15. Saturation concentration of hydrocortisone in WHS diluted 1:1 with HS,
                   WS and white petrolatum
Comparing the systems WHS 1% diluted with WWS 1:1 (Fig. 4.5.) and WWS 1%
diluted with WHS 1:1 (Fig. 4.11.) revealed no significant difference in their liberation
profiles (Fig.4.12.). In conclusion, incorporating the drug in either of the two bases
before dilution does not affect drug release from the final formulation i.e. the
distribution of the drug between the lipophilic and hydrophilic phases in the diluted
preparation is independent of the order of dilution.
In order to confirm this finding the hydrocortisone liberation rate of NHC 1% diluted
with WHS 1:1 was compared with that of the previously investigated system WHS
1%/NHC 1:1 (Fig. 4.8.). Fig. 4.13. reveals that both systems liberate the drug
identically, proving thereby the conclusion mentioned above.
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Fig. 4.12. Release of hydrocortisone from WHS1% diluted with WWS 1:1 and from
                WWS 1% diluted with WHS 1:1
Fig. 4.13. Release of hydrocortisone from WHS1% diluted with NHC 1:1 and from
                NHC 1% diluted with WHS 1:1
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4.2.3. The influence of water content on drug release
Water content is known to influence drug release from semisolid preparations (Niemi
et al., 1989; Junginger, 1991; Preiss, 1993). In this study, regarding the different
undiluted as well as diluted preparations, it was noticed that water content only
affects drug release when incorporated in hydrophilic bases i.e. constituting the
external phase, while having no effect when present in lipophilic vehicles.
In order to reveal the effect of the stepwise reduction of water content in a hydrophilic
base on hydrocortisone liberation, the water content in WHS, which is 70% was
reduced to 50%, 30% and 15%. The obtained formulations were prepared with 1%
hydrocortisone and tested for drug release. The results are illustrated in Fig. 4.14.
Fig. 4.14. Release of hydrocortisone from 1% WHS (70% water content), 1% HS
                (50%), 1% HS (30%) and 1% HS (15%)
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Fig. 4.14. shows that 20% reduction of water content (from 70%-50%) reduced the
drug release more than to the half taking in consideration that it is still an o/w system
(Table 4.16.). This reduction of the water content reduced on the one hand the
amount of dissolved drug in the base (Table 4.17.) and decreased on the other hand
the amount of external aqueous phase (bulk water) in which hydrocortisone is free for
release.
HS 30% and HS 15% showed very low liberation rates without being significantly
different. Colouring and conductivity tests ensured a phase conversion in these
formulations; thus hydrocortisone dissolved in the aqueous phase became fixed in
the inside of the base. It is interesting to note that the release of hydrocortisone from
WHS/HS 1:1 (35% water), which is still an o/w system (4.2.2.1.4) was found to be
significantly higher than from the formulations HS 30% and HS 15% (Table 4.16 and
Fig. 4.15.). This indicates that 5% reduction in water content (from 35%-30%) was
enough to convert the phase. After phase conversion any further reduction in water
content does not influence drug release.
Fig. 4.15. Release of hydrocortisone from WHS 1%/HS 1:1 (35% water), 1% HS
                (30%) and 1% HS (15%),
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Base Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
1% WHS 8.63 5.72
1% HS (50%) 3.58 1.28
WHS1% /HS 1:1 (35%) 1.43 0.63
1% HS (30%) & 1% HS (15%) 0.75 0.133
Table 4.16. Liberation coefficients calculated from the slopes of the liberation curves
                   of 1% WHS, 1% HS (50%), WHS1% /HS 1:1 (35% water), 1% HS (30%)
                   and 1% HS (15%)
Base Cs
[%, w/w]
WHS 0.012
HS (50%) 0.009
WHS/HS 1:1 (35%) 0.0066
HS (30%) & HS (15%) 0.005
Table 4.17. Saturation concentration of hydrocortisone in WHS, WHS/HS 1:1 (35%
                    water), HS (30%) and HS (15%)
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4.2.4. The influence of emulsifier on drug release
It is reported in the previous chapter (4.2.3) that 20% reduction of water content (from
70%-50%) in a hydrophilic base decreased the drug release more than to the half.
Taking in consideration that NHC and WHS have a similar microstructure (4.2.1.) and
the same dissolving capacity for hydrocortisone (Table 4.2.) it is surprising that NHC
despite of having only 50% water possesses the same release rate for
hydrocortisone as WHS with 70% water content (4.2.1.). However, regarding the
composition of both bases it is noticed that they contain different types and amounts
of emulsifiers. WHS contains 9% emulsifying cetostearyl alcohol which is a mixture of
cetostearyl alcohol and sodium cetostearyl sulfate being an anionic emulsifier,
whereas NHC contains 10% cetostearyl alcohol in addition to 5% tween 60 being
both non-ionic emulsifiers.
In order to reveal the influence of emulsifier type on drug liberation the water content
in WHS was reduced to 50% to be equal to that of NHC, simultaneously the amount
of emulsifier in NHC was decreased to 9% (6% cetostearyl alcohol and 3% tween
60), the remaining 6% were replaced by white petrolatum. The resulting formulations
WHS and NHC (water 50% and emulsifier 9%) both containing 1% hydrocortisone
were tested for drug release.
From Fig. 4.16. it is obvious that both bases in spite of having the same amounts of
water and emulsifier differ greatly in their liberation profiles for hydrocortisone. NHC
(9% emulsifier) exhibits a significant greater liberation coefficient than WHS (50%).
(Table 4.18.). This finding could be explained by regarding the drug solubility in both
bases. Table 4.19. reveals the greater solubilizing capacity of the non-ionic surfactant
in NHC for hydrocortisone than does the ionic surfactant in WHS having both the
same water content. This result reveals the pronounced effect of emulsifier type on
drug solubility and subsequently on drug release.
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Fig. 4.16. Release of hydrocortisone from 1% NHC and 1% WHS both containing
                 50% water content and 9% emulsifier
Moreover, comparing the release of hydrocortisone from the formulations NHC with
9% and 15% emulsifier as well as its solubility in these bases no difference could be
detected as shown in Fig. 4.17. and Table 4.19 respectively revealing thereby the
negligible effect of the emulsifier concentration change on hydrocortisone liberation.
Fig. 4.17. Release of hydrocortisone from 1% NHC (9% emulsifier) and 1% NHC
                 (15% emulsifier)
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Similar results were obtained by Turakka and Toikkanen (1983). The authors
reported that maximum steady state release of the drug occurred at surfactant
concentrations of 0.2 to 5%, above that e.g. at concentrations of 10-15% the release
rate was only slightly influenced.
In order to confirm the effect of emulsifier type on the release of hydrocortisone away
from the influence of water content, the systems NHC anhydrous and HS (WHS
anhydrous) were compared with regard to drug solubility and liberation.
Fig. 4.18. Release of hydrocortisone from anhydrous 1% NHC and 1% HS
Fig. 4.18. reveals a significant greater release of hydrocortisone from 1% NHC
anhydrous over 1% HS. This observation is attributed to the pronounced higher
solubility of hydrocortisone in NHC anhydrous compared to HS (Table 4.19.) which
was surprisingly identical to its solubility in NHC (50% water content). It is to be noted
that this effect is opposing that observed for hydrocortisone solubility in WHS, which
was greatly influenced by the amount of aqueous phase.
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This finding allows the conclusion that the water content in vehicles emulsified by
non-ionic emulsifiers does not influence drug solubility as does in bases containing
ionic emulsifiers. These data are in agreement with those of Niemi et al. (1989) who
have reported that the extent of effect of water content on release of hydrocortisone
in the presence of ionic surfactants being more pronounced than that of the non-ionic
ones. Taken together, these results suggest that the water content is not of special
importance in creams containing an emulsifier that does not significantly increase the
amount of hydrocortisone dissolved in the water phase (Niemi et al., 1989).
However, 1% NHC anhydrous shows significant lower liberation profile than NHC 1%
(50% water content) in spite of having same capacity for hydrocortisone. This effect
is probably referred to other factors playing also an important role on drug release
e.g. viscosity.
Base 1% Slope
[µg/cm²* min-0.5]
Liberation coefficient
[10-7 cm²/s]
WHS (50%) 3.58 1.28
NHC (9% emulsifier) 8.23 5.04
NHC 8.33 5.75
NHC (anhydrous) 2.94 0.638
HS 1.63 0.60
Table 4.18. Liberation coefficients calculated from the slopes of the liberation curves
of 1% WHS (50% water), 1% NHC (9% emulsifier), 1% NHC, 1%
anhydrous NHC and 1% HS
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Base Cs
[%, w/w]
WHS (50%) 0.009
NHC (9% emulsifier) 0.012
NHC 0.012
NHC (anhydrous) 0.012
HS 0.005
Table 4.19. Saturation concentration of hydrocortisone in WHS (50% water), NHC
        (9% emulsifier), NHC, anhydrous NHC and HS
4.2.5. Summarized discussion of release experiments
From the results in this chapter the factors affecting drug release from semisolid
preparations could be summarized as follows:
a. Base type:
The emulsion type of the base whether hydrophilic (o/w) or lipophilic (w/o) was found
to directly influence drug release. For all the investigated systems it was proven that
the liberation profiles of the o/w bases were significantly greater than those of the w/o
systems. This was attributed to the significant greater solubility of the hydrocortisone
in these bases and its fast release from the external aqueous phase.
The o/w systems investigated in this study were WHS and NHC 1%, both showed a
significant high liberation profile without being significantly different. All dilution ratios
of WHS 1% with WHS and NHC showed accordingly high liberation rates being lower
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than those of the model cream WHS 1% which was referred to the difference in
concentration gradient between suspended and dissolved parts of the drug upon
dilution.
The dilution of WHS with WWS and HS in the ratio 1:1 resulted also in hydrophilic
systems as was ensured by colouring and conductivity tests resulting in significantly
higher liberation rates than the further dilutions which were proven to be converted
into the w/o system.
All other dilutions of WHS 1% being lipophilic in character showed very low drug
release.
b. Saturation concentration of the drug in the base:
All the tested vehicles are suspension type therefore the degree of solubility of the
drug in the base is considered to play a great role in drug release. All the bases in
this study which showed high liberation rates were associated with relatively high
saturation concentrations of hydrocortisone.
However, an exception was observed in the case of the combination WHS/WWS 1:1
as the low saturation concentration of the drug in this base did not match with its
relatively high liberation rate. It is believed that the effect of the emulsion type, being
an o/w system thus releasing the drug freely from the outer aqueous phase, exceeds
the effect of drug solubility.
c. Type of emulsifier:
The systems WHS/HS 1:1 and WHS/WS 1:1 in comparison to WHS/white petrolatum
1:1 showed the effect of adding a hydrophilic and a lipophilic emulsifier to white
petrolatum respectively. The hydrophilic emulsifier retained the hydrophilic character
of the base at a given water content and in addition it increased the amount of
dissolved drug. Both factors together resulted in a pronounced greater liberation
profile than the formulation WHS/WS 1:1 in which hydrocortisone is emulsified by a
lipophilic emulsifier.
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The type of emulsifier being non-ionic or ionic plays also an important role in drug
release. It was found that the non-ionic surfactant in NHC possesses a greater
influence on drug release and solubility of hydrocortisone than does the anionic
emulsifier in WHS. Besides, in contrast to WHS, it was noticed that for NHC being
emulsified by a non-ionic emulsifier the solubility of hydrocortisone is not affected by
the amount of water present in the base.
d. Water content in o/w systems:
Water content has a major influence on drug release but only when incorporated in
o/w systems. It was observed that reducing water content resulted in all cases in a
significant reduction in drug liberation.
In almost all cases the drug was proven to be dissolved to a great extent in the
external aqueous phase thus reducing the amount of this phase was always
accompanied by a decrease in the amount of hydrocortisone dissolved leading
thereby to decreased liberation rates. This effect was obviously seen in the systems
WHS (50%) and WHS/HS 1:1 (35%) which showed a remarkable reduction in release
rates of hydrocortisone compared with the original preparation WHS (70%).
The only exception was observed in the case of NHC anhydrous which has exactly
the same solubilizing capacity for hydrocortisone as NHC with 50% water content
thus the increased viscosity is probably the reason of the reduced drug release in this
case.
d. Viscosity of the base:
The viscosity of the base, which is believed to have a great influence on drug release
is discussed separately in the next chapter.
The factors, which were found to have no influence on drug release could be
summarized as follows:
a. Order of dilution:
Incorporating the drug in either of the two bases before dilution was proven to have
no influence on drug release from the diluted formulation, indicating that the
distribution of the drug in the final preparation is independent of its distribution in the
base before dilution.
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b. Water content in w/o systems:
The systems WWS 1%, WHS/WWS 1:2 & 1:3, WHS/HS 1:1 & 1:2, all dilution ratios
of WHS/WS and WHS/white petrolatum 1:1 are all w/o systems with different
amounts of water, however they all showed significant low liberation rates which all
lay in the same range. In conclusion, once water is fixed inside the base, the drug
must diffuse through the external more viscous lipophilic phase, which is believed to
be the rate limiting step, therefore any variations in its amount have no influence on
drug release.
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4.3. Rheological examination of the cream bases
A very important factor known to directly influence the drug release from semisolid
preparations is the rheological behaviour of the bases (Korbar et al., 1982; Hsu et al.,
1994; Fang et al., 1996; Fang et al., 1999).
Oscillatory measurement seems to be a suitable method to characterize the systems
for release experiments, because it gives information about the viscous as well as the
elastic properties of the vehicle, thus one could estimate their effect on drug release.
Furthermore, it could help detecting and explaining structural changes following
cream base dilutions. Moreover, oscillatory measurement is performed in the
rheological ground state (viscoelastic range) of the material in which the structure of
the base is still intact. The release of active ingredients from vehicles are intuitively
presumed to have a closer correlation with the static state than the structurally
destroyed state of the vehicle.
The viscoelastic range varies from one base to the other, therefore it was determined
for each base separately by continuously increasing the shear stress at a constant
frequency. At the critical stress point the linear viscoelastic range ends and the
parameters e.g. phase angle, complex viscosity and moduli change their values
drastically.
WHS 1% is taken as an example to illustrate the viscoelastic range (Fig. 4.19.). The
falling of the straight line of the elastic modulus indicates the end of the range i.e. the
vehicle begins to flow.
All systems were investigated in the linear viscoelastic range at a shear stress of 35
Pa except for HS 1% and all WHS/HS combinations, which were tested at 150 Pa,
and NHC anhydrous, which was tested at 100 Pa because at lower shear stress
values the measured parameters fluctuated strongly. The experiment is described in
detail in 3.2.11.
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Fig. 4.19. Determination of viscoelasic range of WHS 1%
4.3.1. Oscillatory measurements of the different cream bases
The vehicles WHS, WWS, HS, WS and NHC with 1% hydrocortisone were
investigated. The parameters determined were complex viscosity, which is the
viscosity of both the viscous and the elastic parts of the base, phase angle, storage
modulus and loss modulus.
The phase angle G is an indicator for the overall viscoelastic nature of the sample
ranging from 0° for an ideal elastic solid to 90° for a completely viscous liquid. As
seen in Fig.4.20. the phase angle for all investigated preparations was lower than 45°
which indicates that the elastic behaviour of the bases exceeds the viscous one.
This finding can also be detected by regarding both moduli (Fig. 4.21.). The storage
modulus G´ describes the elastic behaviour of the vehicle whereas the loss modulus
G´´ characterizes the viscous one. For all samples G´ was greater than G´´.
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Fig. 4.20. Phase angle and complex viscosity of 1% hydrocortisone concentrated HS,
                NHC, WHS, WS and WWS
Fig. 4.21. Storage modulus and loss modulus of 1% hydrocortisone concentrated HS,
                NHC, WHS, WS and WWS
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Regarding the complex viscosity of the bases (Fig. 4.20) and comparing it with the
release experiments it is found that HS possesses the greatest viscosity among all
bases. Both lipophilic bases (WS and WWS) exhibited a remarkably lower viscosity
than that of HS, about 5-6 times lower, without being significantly different.
This finding agrees only partly with the release experiments as the release rate of
hydrocortisone from the lipophilic bases was indeed almost identical, however it was
lower than that of HS. In conclusion, the effect of base type and drug solubility in this
case exceeds the effect of viscosity.
The very low viscosities exhibited by the hydrous hydrophilic vehicles match with
their greatest releasing profiles, nevertheless, the viscosity of NHC being significantly
greater than that of WHS does not agree with the identical release rate of both
bases. The greater viscosity of NHC is probably compensated by the drug release-
promoting effect of the non-ionic emulsifier in NHC resulting in identical drug
liberation to that of WHS.
4.3.2. Oscillatory measurements of the diluted cream bases
4.3.2.1. Oscillatory measurements of WHS 1% diluted with WHS
Fig. 4.22. shows that using the same base for dilution results in neither a change in
viscosity nor an alteration in the phase angle. This result was expected, however the
experiment was carried out in order to investigate whether a double stress of the
base would lead to any variations in the rheological behaviour of the bases. This
double stress arises from using the Unguator twice, the first time for dispersing the
drug in the base and secondly for diluting the base.
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Fig. 4.22. Phase angle and complex viscosity of WHS 1% diluted 1:1, 1:2 and 1:3
      with WHS
4.3.2.2. Oscillatory measurements of WHS 1% diluted with HS
Fig. 4.23. reveals that the phase angle of WHS/HS 1:1 having a value of about 22° is
quite close to that of WHS 1% (18°); however, a significant increase in G to about 30°
is observed for the combinations 1:2 and 1:3. As mentioned previously a phase
conversion takes place for these two formulations (4.2.2.1.4.). In the resulting w/o-
type vehicles the structure of the systems completely changes and water is
presumably dispersed as droplets in the vehicle.
It is known that there are several factors such as volume fraction of the disperse
phase, droplet size, droplet size distribution, internal phase and continuous phase
rheology, the interfacial rheology of the emulsifier film and the concentration and
nature of the emulsifier that may be associated with the rheological properties of the
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cream (Tadros, 1994). Therefore the structural change which occurred upon the 1:2
and 1:3 dilution would surely affect the elastic and viscous behaviour of the bases
resulting in this significant change in phase angle.
Fig. 4.23. Phase angle and complex viscosity of WHS 1% diluted 1:1, 1:2 and 1:3
      with HS
This increase in G would indicate an increase in the viscous behaviour of the
formulations, however from Table 4.20. it is obvious that dilution resulted in an
enormous increase in the values of the loss modulus G´´ and the storage modulus G´
as well. The greater G indicates only that the increase of G´´ is greater than that of G´.
For the 1:1 formulation, which did not suffer from great structural changes, the
balance between loss and storage modulus was not greatly affected, however the
values of both moduli increased, too. The increased elasticity of the creams is
associated with increased consistency and viscosity of the vehicles (Tamburic et al,
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1996). The great increase in viscosity observed for all preparations correlated very
well with the decreased drug liberation from these formulations.
Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
WHS 1% 1873.5 r 32.1 629.1 r 3.3
WHS/HS 1:1 15617.7 r 786.7 5840.3 r 321.4
WHS/HS 1:2 22329.1 r 2613.1 11913.0 r 1093.3
WHS/HS 1:3 26785.0 r 1204.9 141460.8 r 665.73
Table 4.20. Storage modulus and loss modulus of WHS 1% diluted 1:1, 1:2 and 1:3
         with HS
4.3.2.3. Oscillatory measurements of WHS 1% diluted with NHC
No change of the phase angle (about 18°) occurred when WHS 1% was diluted with
NHC (Fig. 4.24.), which means that the ratio between viscous and elastic properties
remained constant upon dilution. This finding matches with the structural similarity
between both bases (Niedner and Ziegenmeyer, 1992). However, the constant phase
angle does not mean constant elastic and viscous properties as it is noticed from
Table 4.21 that dilution resulted in increased viscous and elastic behaviour. The
increased elasticity of the diluted vehicles was accompanied by a slight gradual
increase in viscosity.
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Fig. 4.24. Phase angle and complex viscosity of WHS 1% diluted 1:1, 1:2 and 1:3
      with NHC
Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
WHS 1% 1873.5 r 32.1 629.1 r 3.3
WHS/NHC 1:1 4456.8 r 101.8 1357.13 r 26.0
WHS/NHC 1:2 5590.3 r 116.4 1764.9 r 25.7
WHS/NHC 1:3 7212.1 r 131.3 2297.9 r 41.9
Table 4.21. Storage modulus and loss modulus of WHS 1% diluted 1:1, 1:2 and 1:3
         with NHC
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4.3.2.4. Oscillatory measurements of WHS 1% diluted with WWS
From Fig. 4.25. it is obvious that the combination WHS/WWS 1:1 revealed a phase
angle almost identical to that of WHS 1% while a great increase in G to about 30° is
noticed for the dilution ratios 1:2 and 1:3. This rheological behaviour is quite similar to
that observed for the diluted preparations of WHS with HS. Again here the phase
conversion which was proven for the formulations 1:2 and 1:3 (4.2.2.1.2.) resulted in
a disturbance in the balance between viscous and elastic properties leading to the
significant change in phase angle. Despite of the increase in phase angle which
means increased viscous properties, it is obvious from Table 4.22 that the elasticity
of the bases greatly increased as well which would explain the immense increase in
viscosity of these preparations. This great  increase in viscosity correlates with the
significant drop in drug liberation from these formulations.
Fig. 4.25. Phase angle and complex viscosity of WHS 1% diluted 1:1, 1:2 and 1:3
      with WWS
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Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
WHS 1% 1873.5 r 32.1 629.1 r 3.3
WHS/WWS 1:1 3246.7 r 87.4 1122.9 r 45.1
WHS/WWS 1:2 28278.1 r 1901.9 16234.8 r 890.4
WHS/WWS 1:3 22968.7 r 4314.8 13661.4 r 2330.1
Table 4.22. Storage modulus and loss modulus of WHS 1% diluted 1:1, 1:2 and 1:3
         with WWS
On the other hand, the formulation WHS/WWS 1:1 showed only a slight increase in
viscosity, much lower than that observed for WHS/HS 1:1. This would explain the
greater hydrocortisone liberation from WHS/WWS 1:1 than from WHS/HS 1:1,
despite of the greater solubility of hydrocortisone in the latter.
4.3.2.5. Oscillatory measurements of WHS 1% diluted with WS
A significant increase in phase angle to about 30° was observed for all three dilution
ratios of WHS with WS (Fig. 4.26.) which is again an indication for the structural
change of these formulations to the w/o system.
Again the immense increase in elasticity of the diluted preparations (Table 4.23.)
resulted in a great rise in viscosity which correlates with the drastically reduced drug
liberation of hydrocortisone observed for all WHS/WS combinations.
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Fig. 4.26. Phase angle and complex viscosity of WHS 1% diluted 1:1, 1:2 and 1:3
      with WS
Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
WHS 1% 1873.5 r 32.1 629.1 r 3.3
WHS/WS 1:1 23324.2 r 1293.4 13629.5 r 553.4
WHS/WS 1:2 22955.5 r 1715.6 13988.8 r 858.7
WHS/WS 1:3 29071.2 r 2410.7 17251.6 r 1117.7
Table 4.23. Storage modulus and loss modulus of WHS 1% diluted 1:1, 1:2 and 1:3
         with WS
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4.3.3. Effect of water content on the rheological properties of a hydrophilic
          cream base
For this purpose the systems HS (50%), HS (30%) and HS (15%) with 1%
hydrocortisone were investigated and compared with the model cream WHS (70%).
As shown in Table 4.24. decreasing the amount of water to 50% resulted in a
balanced increase in G´and G´´ i.e. insignificant change in the phase angle, which
was accompanied by an almost 4 times increase in viscosity (Fig. 4.27.). This finding
was also observed by other authors (Taleb and Erõs, 1996) who reported that in
different o/w type creams the rheological characteristics increased exponentially by
decreasing water content. The increase of viscosity could be regarded as a further
explanation for the significant reduction in drug liberation, additional to the reduced
hydrocortisone solubility in the base.
Fig. 4.27. Phase angle and complex viscosity of WHS (70%), HS (50%), HS (30%)
      and HS (15%)
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Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
WHS (70%) 1873.5 r 32.1 629.1 r 3.3
HS (50%) 7469 r 137.3 2760.9 r 35.5
HS (30%) 54776.8 r 4387.2 22171.8 r 2444.3
HS (15%) 30295.5 r 2166.7 13820.1 r 836.3
Table 4.24. Storage modulus and loss modulus of WHS (70%), HS (50%), HS (30%)
        and HS (15%)
The viscosity of the system HS 15% being around 5000 Pas lies in the same range
as the viscosity of the systems WHS/HS 1:2 and WHS/HS 1:3 which contain 23.3%
and 17.5% water, respectively. For these vehicles being all w/o systems, water
content does not have a significant influence on viscosity.
Surprisingly, HS 30%, which was proven to be also a w/o system, showed a
remarkably higher viscosity (about 9400 Pas). This finding may be attributed to the
high instability of this system being on the border between the o/w and the w/o
character as shown before (4.4.3.). This was also noticed optically, as this base was
not easily prepared and it sometimes broke down during preparation.
However, it is to be noticed that the phase angle of the formulations HS (30%) and
HS (15%) increased only slightly  (Fig. 4.27.) and not as much as observed for the
systems WHS/HS 1:2 and WHS/HS 1:3 despite of being probably very similar in
structural arrangement. This observation may be referred to the difference in the
method of preparation. The diluted systems were prepared by mixing HS with the
already prepared WHS on cold, while HS (30%) and HS (15%) were prepared by
directly incorporating the water phase to HS on hot which may lead to different
characters such as droplet size and droplet distribution.
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The effect of water content on the rheological properties was also investigated for
NHC. From Fig. 4.28. it is obvious that NHC anhydrous possesses an enormously
greater viscosity than NHC proving thereby that the increase in viscosity is indeed the
reason why NHC anhydrous reveals a lower liberation rate for hydrocortisone than
NHC despite of both having the same solubilizing capacity for hydrocortisone.
Fig. 4.28. Phase angle and complex viscosity of NHC 1% and NHC 1% (anhydrous)
4.3.4. Effect of emulsifier concentration on the rheological properties of a
          hydrophilic cream base
In order to investigate the effect of the emulsifier concentration on the rheological
properties of the base, NHC, which normally contains 15% of non-ionic emulsifier,
was compared with NHC containing only 9% emulsifier.
It is to be noted that reducing the amount of surfactant resulted in a significant
decrease in the elasticity of the base by almost the factor four (Table 4.25.). This was
associated with a similar decrease in viscosity (Fig. 4.29), which would mean
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increased diffusivity of the drug within the vehicle. From this result one would expect
a greater drug release for NHC (9%) over NHC (15%), however it must be taken in
consideration that the emusifier contributes in promoting drug release, thus an
increase in its concentration would also increase drug release. Therefore it is
suggested that these two opposing effects compensated each other and led finally to
an almost identical liberation profile for both bases.
Fig. 4.29. Phase angle and complex viscosity of NHC 1% and NHC 1% (9%
      emulsifier)
Base Storage modulus
G´ (Pa)
Loss modulus
G´´ (Pa)
NHC (1%) 15059.4 r 396.2 6448.1 r 126.3
NHC 1% (9%
emulsifier)
3634.6 r 226.2 1440.4 r 111.2
Table 4.25. Storage modulus and loss modulus of NHC 1% and NHC 1% (9%
         emulsifier)
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4.3.5. Summarized discussion of the rheological investigation and its
          correlation with the release experiment
From the previous investigations the base type with regard to hydrophilicity,
lipophilicity and composition, as well as drug solubility in the base were found to have
a great influence on drug release. In addition to all these factors the rheological
behaviour of the vehicles was proven to have also a direct influence on drug
liberation. However, sometimes the effect of one of the factors exceeds the effect of
the other factors leading to some contradictions.
Regarding the complex viscosity of the undiluted bases it was found that the effect of
base type on drug release dominates over the effect of viscosity. The lipophilic bases
(WWS and WS), in spite of having much lower viscosities than HS, possess lower
release rates for hydrocortisone.
Moreover, the viscosity of NHC being greater than that of WHS does not agree with
their identical drug release especially in context that they have similar microstructure
and identical dissolving capacity for hydrocortisone i.e. probably the release
promoting effect of the emulsifier in NHC is compensated by its increased viscosity.
The greater viscosity of NHC over WHS may be attributed to the reduced amount of
water in NHC. NHC, with its 50% water content, has a comparable viscosity with that
of WHS which contains 50% aqueous phase.
The dilution of WHS 1% with WS, HS and WWS with the exception of the
combinations WHS/HS 1:1 and WHS/WWS 1:1 showed a phase conversion to the
w/o system as proven in the previous chapter. This great structural change was
expressed in an inbalanced increase in both, the viscous and elastic properties of the
vehicles leading to a significant increase in the phase angle to about 30°. This was
accompanied by a great rise in viscosity which correlates with the enormous drop in
drug release from these formulations.
The formulations WHS/HS 1:1 and WHS/WWS 1:1 which retained their hydrophilic
character with no great structural changes, revealed an insignificant change in the
phase angle. This was a result of a balanced increase in the values of both moduli.
The increased elasticity of the vehicles was accompanied by an increase in viscosity,
the extent of which differed from one base to the other. The viscosity of the
formulation WHS/HS 1:1 was much greater than that of WHS/WWS 1:1 which may
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be referred to the difference in water content. The relatively low viscosity observed
for WHS/WWS 1:1 was accompanied by a relatively high liberation rate whereas the
high viscosity of WHS/HS 1:1 was associated with a remarkably low liberation profile.
Diluting WHS with NHC was accompanied by a gradual increase in viscosity, which
was considered to be the reason for the lower liberation profiles of WHS/NHC
combinations compared to the corresponding WHS/WHS combinations in spite of
possessing the same microstructure and saturation concentration of hydrocortisone.
In this case the increased viscosity seems to be not compensated by the effect of the
emulsifier (as discussed in the case of NHC) which may be attributed to its dilution
(its partial substitution by the anionic emulsifier of WHS).
It is remarkable that the drug release from the dilution ratios of WHS 1% with NHC
was greater than that of WHS/WWS 1:1 in spite of having higher viscosities.
Considering the solubility of hydrocortisone in the different bases helps to explain this
contradiction. The solubility of hydrocortisone in all WHS/NHC combinations is about
4 times greater than its solubility in WHS/WWS 1:1.
The great increase in viscosity upon reducing water content in the o/w bases may
add a further explanation - additional to the reduced drug solubility – for the
significant reduction in drug release. On contrast, investigations show that the
amount of water in the w/o systems has no influence on viscosity; a finding which
agrees with the very close liberation profiles of all tested w/o systems despite of
having different water contents.
In addition, surfactant concentration was also found to have a direct influence on the
rheological properties of the vehicle. Decreasing the concentration of the non ionic
emulsifier in NHC led to a significant decrease in elasticity and viscosity of the
vehicle.
Regarding the phase angle of the pure and diluted vehicles it seemed surprising that
the phase angle of the pure bases (HS, WS, WWS) were all below 30°, however
upon dilution the phase angle increased to above 30° for all bases showing a phase
conversion. Considering the fact that the rheological properties of semisolid systems
are greatly influenced by the ratio of their componenets (surfactants, hydrophilic and
lipophilic phase) as well as many other factors as droplet size, droplet size
distribution and nature and concentration of the emulsifier, one would suggest that
dilution may result in systems having viscoelastic behaviour completely different from
the pure bases.
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4.4. Permeation experiments
The ability of a drug in a topical formulation to exert its effect is dependent on two
consecutive physical events. The drug must first diffuse out of the vehicle to the skin
surface, and then it must permeate this natural barrier to the site of action.
After the release of hydrocortisone from various cream bases, and the effect of
dilution on drug release were investigated in detail in chapter 4.2. it seemed
important to carry on the investigation and examine drug permeation through skin.
There are several possibilities in order to gain information about the permeation of
hydrocortisone through the skin. The in vivo method widely used in the case of
glucocorticoids is the skin blanching assay depending on their vasoconstrictive
property. Alternative to the in vivo method is the in vitro permeation testing mainly
through excised human skin or excised human stratum corneum.
The permeation experiments carried out in this chapter were done through excised
human stratum corneum, which represents the main barrier of the skin, in order to
examine the influence of vehicle composition and the effect of base dilution on
hydrocortisone permeation. The permeation experiments were performed as
described in 3.2.9.2.
4.4.1. Permeation of hydrocortisone from different cream bases
In order to examine the influence of base type on permeation of hydrocortisone
through excised human stratum corneum and to reveal its correlation with the release
experiments the same cream bases, WHS, WWS, NHC, WS and HS with 1%
hydrocortisone were used, taking in consideration that these bases are examples of
hydrophilic as well as lipophilic bases with and without water content. Thus enabling
the investigation of most possible factors concerning vehicle composition that may
exhibit an effect on drug permeation.
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Fig. 4.30. Permeation of hydrocortisone from 1% WHS, WWS, NHC, HS and WS
                through excised human stratum corneum
From Fig. 4.30. it is evident that there is no significant difference between the various
cream bases regarding the permeation of hydrocortisone through excised human
stratum corneum. According to the equation 2.5. the drug flux [g/cm²*s] could be
calculated from the linear part of the curves. In order to neglect the influence of the
starting concentration c0 as well as the saturation concentration cs of the drug in the
vehicle on permeation, the permeation coefficient P as well as the persol-coefficient Z
were determined according to the equations 2.6. and 2.8., respectively.
The starting concentrations of hydrocortisone in the various vehicles are slightly
different despite of being all 1% g/g concentrated. The reason for this contradiction is
that, according to the equation 2.5., the concentration must be given in g/cm³.
Therefore, differences in the densities of the various bases would lead to differences
in the starting concentrations. The data are illustrated in Table 4.26.
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Vehicle (1%
hydrocortisone)
Flux J
(g/cm²*s)* 10-12
Permeation coef. P
(cm/s)
 * 10-9
Persol-coef Z
(cm/s)
 * 10-9
HS 12.35 ± 3.2 1.42 ± 0.37 273.72 ± 71.0
WS 11.38 ± 1.89 1.34 ± 0.22 1335.29 ± 222.4
WHS 9.72 ± 1.83 1.01 ± 0.19 84.6 ± 15.9
WWS 9.6 ± 0.75 1.06 ± 0.08 529.28 ± 41.6
NHC 7.34 ± 3.31 0.76 ± 0.35 63.82 ± 28.8
Table 4.26. Hydrocortisone flux, permeation coefficient and per-sol coefficient of 1%
                    WHS, WWS, NHC, WS and HS
From the table it is obvious that WS 1% and HS 1% have greater fluxes and
permeation coefficients than the other bases, but this observation is not significant as
the standard deviations of the single curves overlap.
The great differences in the per-sol coefficient of the various bases varying from
1335,29 * 10-9cm/s for WS 1% to 84.6 * 10-9cm/s for WHS 1% though having similar
permeation rates indicate the negligible role of the amount of drug dissolved in the
bases on permeation through stratum corneum.
This finding allows the conclusion that the drug release experiments do not correlate
with the permeation experiments through human stratum corneum, as the factors
affecting drug release such as vehicle composition, drug solubility in the base and
viscosity of the preparation do not play a role in drug permeation.
The lack of correlation between release and permeation experiments was also
reported by other authors. Zatz et al. (1996) examined the release of betamethasone
dipropionate from petrolatum-based ointments with two different formulations and
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found that the ointment with the greater release was the less clinically effective of the
two. Hsu et al. (1993) reported that the release of piroxicam from FAPG base
decreased with addition of fatty acids to the base due to an increase in the
lipophilicity and viscosity of the vehicle, whereas the addition of fatty acids increased
the percutaneous absorption of piroxicam due to their enhancer effect. The influence
of replacing different portions of the water content in WHS by ethanol on
hydrocortisone acetate release and permeation through excised human stratum
corneum was investigated (Alberg, 1998), no correlation was again found between
permeation and release experiments.
In order to interpret these results it should be first considered, whether the drug is
suspended or dissolved in the vehicle. In case of suspension bases the quantity Q of
the drug diffused from the vehicle V through the skin barrier is calculated as follows
(Lippold, 1981):
t
d
CfVFFDQ sVV  (Eq. 4.1.)
D = Diffusion coefficient of the drug in stratum corneum
F = Permeation area
VK = partition coefficient between barrier and vehicle
fV = fraction of the drug in the vehicle available for permeation
csV = saturation concentration of the drug in the vehicle
d = thickness of stratum corneum
t = time
The above equation reveals a direct relationship between saturation concentration of
the drug in the vehicle and the amount of drug permeating stratum corneum.
Accordingly, one should expect a change in the vehicle i.e. change in the amount of
the drug dissolved in the vehicle would be associated with an alteration in the
substance transport. However, it should be taken in consideration that a change in
the saturation concentration is accompanied by a reverse change in the partition
coefficient.
The partition coefficient of a substance between an organic phase and an aqueous
phase is described in equation 4.2.:
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forg and faq are fractions of the substance available for diffusion (free, unbound) in the
organic phase and in the aqueous phase, respectively.
Subsequently the partition coefficient of the drug between the stratum corneum
barrier (B) and vehicle (V) is described as follows:
sVV
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 (Eq. 4.3.)
Resulting from equation 4.1. and 4.3. the transport of the drug through stratum
corneum is illustrated in equation 4.4.:
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 (Eq. 4.4.)
This is simplified to:
tCf
d
FDQ sBB  (Eq. 4.5.)
From the above equation it is evident that the factor affecting drug transport through
stratum corneum is the saturation concentration of the drug in stratum corneum csB
which is specific to the substance and not the solubility of the drug in the vehicle as
long as there is enough free (dissolved) substance able to saturate the barrier. In
conclusion, changing the vehicle does not influence drug permeation as proved in
Fig. 4.30.
This finding was also observed by Schwarb et al. (1999), who reported that in
contrast to the in vitro release testing for fluocinonide, the in vivo human skin
blanching assay was found to be independent of the degree of saturation.
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Furthermore, an early publication of Ostrenga et al. (1971) reported that polyacrylate
gel containing 0.025% fluocinolone acetonide with varying proportions (5-25%) of
propylene glycol/water mixtures -which act as solubilizing agent- revealed similar
percutaneous absorption in spite of having different degrees of saturation due to
variable propylene glycol content. This result is not surprising as it was found that up
to 25% propylene glycol the drug is still suspended in the vehicle.
On the other hand, a significant influence of the vehicle on percutaneous absorption
is observed when the drug is dissolved. The affinity of the drug to the vehicle in this
case plays the major role on permeation. A great affinity between drug and vehicle is
associated with a relatively low barrier/vehicle partition coefficient, accordingly a low
permeation rate. In contrast, great permeation rates are expected in the case of low
affinity between drug and vehicle (Lippold, 1981).
These facts altogether lead to the conclusion that as long as the drug is suspended
in the base the degree of saturation, hence the type of vehicle does not influence
permeation through excised stratum corneum.
Nevertheless, if the experiments were performed in vivo the effect of occlusion may
play a role on drug permeation. The application of an ointment on the skin surface
prevents evaporation of water and develops a state of increased hydration of the
skin. Hydration results in increased drug penetration. Application of creams and
lotions under normal conditions (non-occluded) allows free exchange of air and
water, and the skin does not achieve the state of higher hydration. Thus different
formulations may result in different amounts of drug permeation into the skin and
may, thus, exhibit different intensities of activity (Shah et al., 1991). The authors
reported an in vitro release of hydrocortisone in the order of lotion>cream>ointment,
whereas the pharmacological response was in the reversed order.
All the above mentioned facts are true in the case of intact skin. If we look at
damaged skin and mucosa the relations are completely different. Here the release is
the rate limiting step for the drug uptake due to the absence or leakage of stratum
corneum. When formulations are developed for damaged skin or mucosa, an
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increase of the drug concentration, or raised drug solubility always increases the
release rate and thereby the drug uptake (Lippold, 1984).
Furthermore, it must be taken in consideration that the vehicle composition is mostly
altered when the formulation is applied on the skin, e.g. change in the water content
due to evaporation or in the lipid composition due to possible interactions with the
lipids of stratum corneum.
4.4.2. Permeation of hydrocortisone from diluted cream bases
In order to investigate the influence of dilution on hydrocortisone permeation through
excised human stratum corneum WHS 1% was diluted in the ratio 1:1 with the same
base, WHS, and the different chosen cream bases WWS, WS, NHC and HS.
Fig. 4.31. Permeation of hydrocortisone from WHS 1% diluted 1:1 with WHS, WWS,
                NHC, WS and HS
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From Fig. 4.31. it is clear that no remarkable differences can be detected between
the permeation rates of all diluted formulations. This was expected as the permeation
profiles of the different undiluted bases were similar as shown in Fig. 4.30.
Furthermore, the permeation rates of the diluted as well as the undiluted (WHS 1%)
preparations cannot be distinguished from each other, which reveals the negligible
influence of dilution on permeation. The flux, permeation coefficient and the per-sol
coefficient were again calculated and demonstrated in Table 4.27.
Vehicle Flux J
(g/cm²*s)* 10-12
Permeation coef. P
(cm/s)
 * 10-9
Persol-coef Z
(cm/s)
 * 10-9
WHS 1% 9.72 ± 1.83 1.01 ± 0.19 84.6 ± 15.9
WHS/HS 1:1 9.28 ± 1.56 2.02 ± 0.35 154.63 ± 26.5
WHS/WS 1:1 7.8 ± 0.98 1.67 ± 0.21 433.33 ± 54.6
WHS/WHS 1:1 7.6 ± 0.57 1.58 ± 0.12 66.09 ± 4.9
WHS/WWS 1:1 7.68 ± 1.97 1.56 ± 0.40 236.31 ± 60.6
WHS/NHC 1:1 7.77 ± 1.32 1.66 ± 0.28 69.38 ± 11.78
Table 4.27. Hydrocortisone flux, permeation coefficient and per-sol coefficient of
                   WHS 1% diluted in the ratio of 1:1 with the various cream bases.
Diluting WHS 1% 1:1 with all selected vehicles with exception of HS gave almost
identical fluxes being significantly lower than that of WHS 1%. The relatively higher
flux of the formulation WHS/HS 1:1 correlates well with the fact that HS 1% shows
the highest flux among the undiluted bases (Table 4.26.). However, a similar effect
was not observed with the dilution WHS/WS 1:1, although WS 1% has a higher flux
when compared with the other bases. Taken together, these results suggest that all
these slight differences in the fluxes of the diluted as well as the undiluted
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formulations are not significant especially because the standard deviations of all
single curves overlap.
In order to confirm this result, higher dilutions of WHS 1% were performed. WHS 1%
was diluted with a lipophilic base, WWS, as well as with a hydrophilic base, NHC, in
the ratio 1:3 and examined for permeation of hydrocortisone. The results are shown
in Fig. 4.32 and Fig. 4.33, respectively.
Fig. 4.32. Permeation of hydrocortisone from WHS 1% diluted 1:1 and 1:3 with WWS
Fig. 4.33. Permeation of hydrocortisone from WHS 1% diluted 1:1 and 1:3 with NHC
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The figures show that even the 1:3 dilution of WHS 1% with either of the two bases
chosen does not lead to a reduced permeation of hydrocortisone. These results
suggest that the permeation of hydrocortisone through excised human stratum
corneum is independent of the drug concentration in the applied base in addition to
the  type of vehicle as mentioned previously. A similar observation was reported by
Stoughton and Wullich (1989) who reported that higher glucocorticoid concentrations
do not cause higher activity or bioavailability.
It must be considered that hydrocortisone in all diluted formulations is still suspended
in the vehicle to a great excess (Table 4.2.) i.e. the dilution only reduced the amount
of the drug suspended in the base, whereas the vehicle is still saturated with the
drug. According to equation 4.5. the permeation rate of a drug through stratum
corneum is directly influenced by its saturation concentration in the stratum corneum
csB which is specific to the drug. As long as the same drug is used for permeation, the
csB is retained unchanged, thus no change should be expected in the permeation
even if the vehicle or the concentration of the drug in the vehicle are altered.
According to these considerations the amount of drug suspended in the vehicle
whether high or low does not play a role on drug permeation through stratum
corneum (Lippold, 1981) i.e. in order to influence drug permeation very high dilutions
(up to 1:100) should be performed to reduce the drug content in the vehicle below its
saturation concentration. These dilutions were not carried out in this work as they are
not done in practice.
These data are in agreement with those of Magnus et al. (1981) who reported that
Betnovate cream diluted with several cream bases showed good stability and the
potency of the dilutions were equivalent to the undiluted cream. Similar dilutions of
Betnovate ointment (Ryatt et al., 1983) with Unguentum Merck did not reduce the
potency of the ointment up to a dilution of 1:32.
Moreover, the vasoconstrictive effect of fluocinolone acetonide in the commercially
available Synalar preparations (gel, cream and ointment) was investigated (Gao and
Li Wan Po, 1994) (marketed in Germany under the brand name Jellin). The (1 in 4)
and (1 in 10) diluted products appeared to be of the same potency as the full strength
cream. The authors suggested that even at the 1 in 10 dilution, sufficient
corticosteroid is present to saturate the receptors of corticosteroids in the skin, so
that an increase in concentration will not produce any enhancement in activity.
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Generally, in an attempt to overcome the problems arising from skin impermeability,
various approaches to reversibly remove barrier resistance have been investigated.
Among these approaches is the use of permeation enhancers, which are known to
allow drugs to permeate more readily to the viable tissue (Golden et al, 1986;
Leopold et al, 1995; Gorukanti et al, 1999). Therefore, it was interesting to investigate
the influence of diluting a vehicle containing an enhancer on hydrocortisone
permeation through excised stratum corneum.
Among the great number of important enhancers reported in literature (Barry, 1987a),
isopropyl myristate as an example of fatty acid esters was chosen for its pronounced
enhancing effect (Gorukanti et al., 1999). Soventol cream, which contains isopropyl
myristate was found to significantly promote the permeation of hydrocortisone
acetate through stratum corneum when compared with other commercial products
(Alberg, 1998). It is to be noted that Soventol cream contains also isopropyl alcohol
which is known to possess also an enhancing effect. Therefore, Soventol cream
placebo prepared with 1% hydrocortisone and its 1:2 dilution with WHS were tested
for permeation of hydrocortisone in comparison to WHS 1%. The results are shown in
Fig. 4.34 and Table 4.28.
Fig. 4.34. Permeation of hydrocortisone from 1% Soventol cream, Soventol cream
                diluted with WHS 1:2 and 1% WHS
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From Fig. 4.34. it is to be noted that hydrocortisone is permeating significantly better
from Soventol cream than from WHS. As shown in Table 4.28. the permeation of
hydrocortisone from Soventol cream is about 20 times greater than that of WHS
proving thereby the influence of the permeation enhancer.
Vehicle Flux J
g/cm²*s*10-10
Perm.coef. P
cm/s*10-9
Soventol 1% 4.5 ± 0.8 43.06 ± 7.65
Soventol/WHS 1:2 0.85 ± 0.15 25.87 ±  4.61
WHS 1% 0.23 ± 0.07 2.39 ± 0.71
Table 4.28. Hydrocortisone flux and permeation coefficient of 1% Soventol cream,
                    Soventol cream diluted with WHS 1:2 and 1% WHS
Isopropyl myristate being a long-chain saturated fatty acid ester was shown to
increase the fluidity of the lipid portions of stratum corneum, and thereby enhances
the permeability of the skin layers for drug molecules (Golden et al., 1987 a).
Isopropyl alcohol causes only some lipid extraction but no fluidization of the
intercellular domains (Guy et al. 1989).
A very interesting result was revealed by the permeation rate of the diluted
formulation of Soventol cream/WHS 1:2. Fig. 4.34. shows the considerable reduction
of hydrocortisone permeation flux which was found to be about five times lower than
that of Soventol 1% (Table 4.28.) (the permeation coefficient is relatively high
because the starting concentration is reduced to the third). Considering the fact that
hydrocortisone is suspended in the base these results strongly suggest that the
reduced permeation profile of hydrocortisone from Soventol cream upon dilution is
probably due to the reduced concentration of the enhancer and not that of the drug.
This finding allows the conclusion that dilution of cream bases could indeed alter drug
permeation depending on the vehicle composition in a manner which could not be
predictable, i.e. the 1:2 dilution of Soventol cream resulted in a 1:5 reduction in drug
permeation.
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Summarized discussion of the permeation experiments
The permeation profiles of hydrocortisone from different cream bases through
excised human stratum corneum were found to differ insignificantly. The type of the
base whether hydrophilic or lipophilic, water content, viscosity and the degree of
saturation of the drug in the vehicle seem to play no role in drug permeation through
stratum corneum. For all the preparations being suspension vehicles the variations in
drug solubility in the formulation through changing the vehicle is always compensated
by the reverse change in the partition coefficient of the drug between vehicle and
stratum corneum, thus having no influence on drug permeation through stratum
corneum. From equation 4.5. it was evident that the factor affecting permeation is the
saturation concentration of the drug in the stratum corneum which is drug dependent.
Diluting 1% WHS with the other bases in the ratios 1:1 or 1:3 did not influence
hydrocortisone permeation revealing the negligible effect of dilution on drug
permeation. It should be noted that the diluted bases are still suspension vehicles,
thus the two factors which were altered through dilution, the vehicle composition and
the amount of the drug suspended in the vehicle, have no influence on permeation as
mentioned above.
However, if the vehicle contains a permeation enhancer, which is capable of causing
change in the barrier structure of the stratum corneum, the permeation of the drug
through the stratum corneum is significantly promoted. Soventol cream which
contains isopropyl myristate as well as isopropyl alcohol as enhancers showed a
remarkable increase in hydrocortisone permeation compared with WHS 1%.
Moreover, diluting Soventol cream with WHS in the ratio 1:2 caused a great decrease
in permeation profile of hydrocortisone due to reduced enhancer concentration.
Briefly, it could be noted that, any suspension-type vehicle exerts its effect,
independent of the base used and of the drug concentration beyond saturation
provided that there is enough substance to guarantee a constant flux for application
interval; drug liberation is fast enough and there are no specific effects on the skin
barrier (Malzfeldt et al., 1989).
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4.5. Influence of vehicle on structure of stratum corneum
Stratum corneum, the outermost layer of the skin, provides an outstanding barrier
against the external environment and is also responsible for skin impermeability
towards most solutes. The barrier function is related to the unique composition of the
stratum corneum lipids and their complex structural arrangement. Alteration in the
lipoidal matrix of the stratum corneum, therefore, increases its permeability. A
number of physical techniques are used to gain information about structure of
stratum corneum. Some of these techniques are differential thermal analysis, wide
angle and small angle x-ray diffraction and infra-red spectroscopy (Bouwstra et al.,
1991). In the following chapter differential scanning calorimetry as well as wide angle
x-ray diffraction were used to investigate the interactions between vehicles used for
permeation and structure of stratum corneum, which could provide a further
explanation for the results obtained in the permeation experiments.
4.5.1. Differential scanning calorimetry of stratum corneum
4.5.1.1. Differential scanning calorimetry of stratum corneum pretreated with
                 WHS, WWS, WS, NHC and HS
Isolated sheets of human stratum corneum show four characteristic endothermic
transitions at about 40, 75, 85 and 105°C respectively (Van Duzee, 1975; Golden et
al., 1987 b; Leopold et al., 1995). The first three transitions are lipid-based since they
disappear after extraction of the samples with organic solvents.
The first transition is generally small and its occurrence varies from sample to
sample. Until recently it has been attributed to the melting of sebaceous lipids
(Golden et al., 1986). Today it is thought to represent a transition from an
orthorhombic (crystalline) to a hexagonal lipid (gel state) subcell arrangement within
the lipid bilayers (Bouwstra et al., 1992). The two thermal transitions at 75 and 85°C
have been reported to represent phase transitions of the lipid bilayers from the
lamellar gel state to the liquid crystalline state (Bouwstra et al., 1991). The transition
at 85°C is considered by several investigators to represent a phase transition of lipids
which are associated with proteins (Golden et al., 1987 b; Barry et al., 1991;
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Bouwstra et al., 1991). The fourth transition at 105°C represents the denaturation of
the protein portion of the stratum corneum, i.e. the D proteins (Van Duzee, 1975).
The enthalpy of this transition is very sensitive for the water content in the stratum
corneum. At lower water contents (less than approximately 15% w/w) this transition
completely disappears (Bouwstra et al., 1991).
Generally, in order to obtain more distinct endothermic transitions the stratum
corneum sheets should be hydrated to about 20% w/w (Van Duzee, 1975).
Therefore, the stratum corneum sheets were incubated at room temperature for 48
hrs in a closed chamber of 75% relative humidity.
It has to be mentioned that the first peak, which is not easily detectable, as well as
the D protein denaturation peak, which requires a certain water content of the sample
in order to become apparent, could not be detected. Therefore, all DSC curves were
evaluated with regard to the peak maximum temperatures of the distinct lipid-phase
transitions at about 70 and 80°C. These two transitions give the required information
about any possible interaction between the vehicle and the lipoidal structure of the
stratum corneum, which is responsible of its barrier function.
The isolated human stratum corneum sheets were pretreated with the vehicles for 30
minutes at 37°C and the experiment was performed as described in 3.2.2. Typical
DSC thermograms of untreated stratum corneum as well as stratum corneum
pretreated with the various chosen vehicles containing 1% hydrocortisone are shown
in Fig. 4.35.
Fig. 4.35. and Table 4.29. show that none of the tested bases produced significant
changes in the lipid-phase transitions of the stratum corneum, as the maximum peak
shift observed was 1.6°C which is considered to be insignificant. In conclusion, the
vehicles investigated do not interact with stratum corneum structure; therefore, the
barrier properties and subsequently the permeability of the stratum corneum remain
unchanged. These results explain why all tested vehicles showed similar permeation
profiles.
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Fig. 4.35. DSC thermogram for untreated and vehicle (1% hydrocortisone) pretreated
                stratum corneum. Donor: Male, abdomen, 26 years
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Stratum corneum Peak 1 (C°) Peak 2 (°C)
untreated 69.9 80.4
WWS 1% 68.3 79.8
NHC 1% 70.5 80.4
WHS 1% 68.8 80.4
WS 1% 71.4 80.7
HS 1% 70.7 80.1
Table 4.29. Peak maximum temperatures of the second and third phase transitions of
                   untreated and 1% vehicle pretreated stratum corneum. Donor: Male,
                   abdomen, 26 years
The peaks detected at temperatures below 70°C were considered to be produced
from the base rests which remain adhering to the stratum corneum after
pretreatment. To ensure this, all vehicles were also measured separately. Fig 4.36a,
b, c, d and e reveal peaks characteristic to the bases at temperatures below 70°C for
WWS, NHC, WHS, WS and HS respectively.
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c           d
e
Fig. 4.36a, b, c, d and e DSC examination of 1% WWS, NHC, WHS, WS and HS
                                       respectively
To prove the absence of any interferrence due to the presence of hydrocortisone in
the bases, the DSC interaction experiment was repeated using stratum corneum
pretreated with hydrocortisone free vehicles. It is to be noted that identical results like
those shown in Fig. 4.35. and Table 4.29. were obtained proving thereby that
hydrocortisone does not influence the DSC curves exhibited by the vehicles.
Testing the 1:1 diluted vehicles for their interaction with stratum corneum seemed to
be not important, as it is expected to have no influence on stratum corneum structure
since the pure bases did not show any effect.
0 30 60 90
-800
-600
-400
-200
SC
 (µ
W
)
Temperature (°C)
20 40 60 80
2000
2500
3000
3500
4000
D
SC
 (µ
W
)
Temperature (°C)
 WHS 1%
0 30 60 90
0
1000
2000
3000
4000
5000
D
SC
 (µ
W
)
Temperature (°C)
 WS 1%
 HS 1%
4. Results and discussion 114
4.5.1.2. Differential scanning calorimetry of stratum corneum preatreated with
             Soventol cream, isopropyl myristate and isopropyl alcohol
The permeation rate of Soventol cream with 1% hydrocortisone was significantly high
compared with that of WHS 1% (Fig. 4.34.). In order to explain this finding the
interactions between Soventol cream and stratum corneum were investigated via
DSC.
Fig. 4.37. DSC thermogram for human stratum corneum after pretreatment with
                1% Soventol cream. Donor: Male, breast, 26 years
The pretreatment of human stratum corneum with 1% Soventol cream revealed a
significant shift of about 5°C to lower temperatures in both peaks (Fig. 4.37. and
Table 4.30.). This shift indicates an alteration in the lipoidal structure of stratum
corneum which is known to be responsible for its barrier properties subsequently
leading to an increase in its permeability. This result, therefore, explains the
remarkable high permeation rate of hydrocortisone from Soventol cream compared to
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that of WHS which was found to have no interaction with stratum corneum lipids (Fig.
4.35.).
Stratum corneum Peak 1 (C°) Peak 2 (C°)
Untreated 72.68 84.53
Pretreated with Soventol cream 66.86 78.97
Table 4.30. Peak maximum temperatures of the second and third phase transitions of
                    untreated and soventol cream pretreated stratum corneum. Donor: Male,
                    breast, 26 years
This result is believed to be referred mainly to the presence of isopropyl myristate
which is known to possess a pronounced penetration enhancing effect (Fang, 1996).
To investigate whether the observed effect is indeed caused by isopropyl myristate
an interaction experiment between stratum corneum and isopropyl myristate was
performed. As expected similar alteration of the phase transition temperatures of the
stratum corneum lipids was observed upon treatment with isopropyl myristate (Fig.
4.38 and Table 4.31.).
Fig. 4.38. DSC thermogram for human stratum corneum after pretreatment with
                isopropyl myristate. Donor: Male, breast, 26 years
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Stratum corneum Peak 1 (C°) Peak 2 (C°)
Untreated 72.44 82.84
Pretreated with isopropyl myristate 65.71 77.94
Table 4.31. Peak maximum temperatures of the second and third phase transitions of
                   untreated and isopropyl myristate pretreated stratum corneum. Donor:
                   Male, breast, 26 years
This phenomenon may be interpreted as an increase in fluidity of the lipid bilayers;
apparently interactions between the permeation-enhancing compound and the
intercellular lipids lead to a less ordered state of the latter (Leopold et al., 1995).
This fluidizing action is interpreted either by the development of arrangements with
periodic undulations (Rolland et al., 1991) or the formation of solid solutions (lamellar
gel states consisting of a homogeneous mixture of the lipids and the vehicle
molecules).
The reason for the fluidizing effect of isopropyl myristate might be its branched
structure (Leopold et al., 1995). Isopropyl myristate is believed to operate similar to
oleic acid by penetrating into the lipid structure with its polar end close to the lipid
polar heads (Smith and Maibach, 1995) (Fig. 4.39.). Because of its branched
structure, it then disrupts the packing of the intercellular lipids and increases their
fluidity. Drug mobility in this less tightly packed arrangement will then increase (Barry,
1987 a).
Fig. 4.39. Scheme illustrating the mode of action of oleic acid as penetration
                enhancer (Barry, 1987 a).
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In order to reveal the role of isopropyl alcohol in enhancing hydrocortisone
permeation, a similar interaction experiment was carried out.
Fig. 4.40. DSC thermogram for human stratum corneum after pretreatment with
                isopropyl alcohol. Donor: Female, breast, 57 years
Stratum corneum Peak 1
(C°)
Peak 2
(C°)
Enthalpy of both peaks in a temperature
range of ~ 47-105°C (mJ/mg)
Untreated 73.09 84.42 18.0
Pretreated with
isopropyl alcohol
72.67 84.42 15.8
Table 4.32. Peak maximum temperatures of the second and third phase transitions
                   and the enthalpy of both peaks of untreated and isopropyl alcohol
                   pretreated stratum corneum. Donor: Female, breast, 57 years
Isopropyl alcohol is known to act mainly via extraction of stratum corneum lipids,
therefore the DSC curves were evaluated with regard to the peak maximum
temperatures of the lipid-phase transitions as well as the phase transition enthalpies.
Fig. 4.40. and Table 4.32. show that the pretreatment of stratum corneum with
isopropyl alcohol did not reveal a significant alteration in the phase transition
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temperatures. Moreover, the effect observed in the phase transition enthalpies
(~12.2%) was considered to be also insignificant (Leopold and Lippold, 1995
reported a statistically significant effect for an enthalpy change of more than 17%).
This finding proves that isopropyl myristate is alone responsible for the great
permeation profile of hydrocortisone from Soventol cream.
4.5.2. Wide- angle X-ray diffraction (WAXD) of human stratum corneum
Wide-angle X-ray experiments are used to investigate the molecular organization of
barrier components of human stratum corneum. It gives information about the lipid
packing arrangements in the intercellular bilayers as well as the protein structure in
the intracellular keratin. WAXD experiments were performed to detect the interactions
between the vehicles used for permeation and stratum corneum structure in order to
confirm thereby the results obtained in the DSC-experiments.
In the untreated stratum corneum two characteristic sharp and intense reflections at
0.367 and 0.409 nm were observed (Table 4.33.). The diffraction ring at 0.367
corresponds to an orthorhombic crystalline structure, while the reflection at 0.409 is
probably due to hexagonal packing of the alkyl chains (White et al., 1988).
Normally, two diffuse diffraction rings at 0.46 nm and 0.98 nm are detected in human
stratum corneum. The reflection at 0.46 nm is suggested to be due both to
hydrocarbon chains in the liquid state and to soft keratin located in the corneocytes,
whereas the diffraction ring at 0.98 is only attributed to soft keratin (Bouwstra et al.,
1992). These two reflections are not detected in the present work.
Since the reflections at 0.367 and 0.409 nm become sharper upon hydration of
stratum corneum from 6-20% (Bouwstra et al., 1992) the stratum corneum sheets
were incubated for 48 hrs in a closed chamber of 75% humidity to obtain a water
content of 20% w/w. The wide angle X-ray diffraction experiments were performed as
described in 3.2.3.
4.5.2.1. Wide- angle X-ray diffraction (WAXD) of human stratum corneum of
             WHS, WWS, WS, HS and NHC
Table 4.33. shows the lack of interaction between all tested vehicles and the lipoidal
structure of stratum corneum as the two reflections at 0.367 and 0.409 nm remained
unchanged after pretreatment. In conclusion, no change in the permeability of
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stratum corneum for hydrocortisone should be expected using different vehicles for
permeation. This result is in agreement with that obtained in the differential scanning
calorimetry study.
Stratum corneum
pretreated with
Diffraction ring
[nm]
- 0.367 0.409
WHS 1% 0.367 0.409
WS 1% 0.367 0.409
WWS 1% 0.367 0.409
NHC 1% 0.367 0.409
HS 1% 0.367 0.409
Table 4.33. Wide-angle X-ray diffraction of untreated and with 1% WHS, WS, WWS,
                   NHC and HS pretreated stratum corneum. Donor: Male, abdomen, 26
                   years
4.5.2.2. Wide-angle X-ray diffraction (WAXD) of human stratum corneum
             pretreated with 1%Soventol cream
Treating the stratum corneum with soventol cream which is known to contain a
permeation enhancer, isopropyl myristate, induced an obvious shift of the two
reflections to higher values (Table 4.34.). This shift indicates an alteration in the
intercellular lipid domains of stratum corneum leading to its increased permeability
towards permeation substances.
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Stratum corneum
pretreated with
Diffraction ring
[nm]
- 0.367 0.409
Soventol cream 0.371 0.413
Table 4.34. Wide-angle X-ray diffraction of untreated and with Soventol cream
                   pretreated stratum corneum. Donor: Male, abdomen, 26 years
WAXD experiments for stratum corneum pretreated with isopropyl myristate and
isopropyl alcohol were not carried out because there was no more stratum corneum
of the same donor available. Their effect is expected to match with the DSC
investigations like all previous results.
4.5.3. Summarised discussion of differential scanning calorimetry and wide-
          angle X-ray diffraction experiments and their correlation with the
          permeation study
The vehicles WHS, WWS, NHC, HS and WS containing 1% hydrocortisone neither
produce significant change in the peak maximum temperatures of the distinct lipid
phase transitions at about 70 and 80°C nor change the reflections of the intercellular
lipid domains of the stratum corneum. These findings obtained from the differential
scanning calorimetry study as well as the wide angle X-ray diffraction experiments
respectively, allow the conclusion that the components of these vehicles (the
lipophilic phase, hydrophilic phase, water content and surfactants) do not interact
with the lipoidal structure of the stratum corneum thus having no influence on its
barrier properties. Subsequently, its permeability towards permeating substances
remains unchanged. This finding adds a further explanation to the results obtained in
the permeation experiments as the permeation profiles of hydrocortisone from all
investigated vehicles through stratum corneum were found to differ insignificantly.
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Nevertheless, pretreating stratum corneum with Soventol cream revealed a shift of
the peak maximum temperatures of the second and third phase transitions of the
stratum corneum of about 5°C to lower temperatures. Moreover, the wide-angle X-
ray diffraction study showed a shift in both reflections at 0.367 and 0.409 nm to
higher values. Both shifts indicate the disruption of the packing of the intercellular
lipids of the stratum corneum.
This effect was thought to be attributed to the presence of isopropyl myristate which
is known to act as a penetration enhancer. Its effect on stratum corneum structure
was investigated using differential scanning calorimetry technique. It is to be noted
that similar shifts of the second and third phase transitions to lower temperatures
were observed. Isopropyl myristate is believed to penetrate into the lipid structure of
stratum corneum with its polar end close to the lipid polar heads increasing thereby
the fluidity of the intercellular lipids.
This result interprets the significant high permeation rate of 1% Soventol cream over
that of WHS 1% which was proven to cause no alteration in the structure of stratum
corneum. Taken altogether, these results suggest that the great reduction in the
permeation profile of hydrocortisone from the diluted formulation (Soventol
cream/WHS 1:2) is attributed to reduced enhancer concentration and not to the
decrease in hydrocortisone concentration.
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5. Conclusion
The influence of diluting semisolid preparations on drug release and permeation
through excised human stratum corneum was investigated. For this purpose the
model cream, water containing hydrophilic ointment DAB 1998 (WHS) with 1%
hydrocortisone was diluted with various hydrophilic and lipophilic bases chosen from
the German Pharmacopoeia 1998. Moreover, the different factors affecting
hydrocortisone liberation and permeation were investigated in order to be able to
interpret the different liberation and permeation profiles.
5.1. Drug release experiments
WHS as well as the other cream bases, NHC, WS, WWS and HS were prepared with
1% hydrocortisone and tested for drug liberation in order to reveal the influence of
the base type whether lipophilic, hydrophilic, hydrous or anhydrous on drug release.
It was evident that o/w systems (WHS, NHC) revealed very high release rates in
contrast to the anhydrous hydrophilic and lipophilic bases (WS, HS) and w/o system
(WWS) which showed remarkably low liberation profiles. This finding was referred to
the fast and free release of hydrocortisone from the external aqueous phase of the
o/w vehicles in addition to the relatively high solubility of hydrocortisone in these
bases. The great influence of water content observed in the hydrophilic bases on
drug release and solubility (WHS, HS) was not noticed in the case of the lipophilic
vehicles, as WS and WWS showed almost identical liberation rates associated with
very low solubility of hydrocortisone. The slightly greater release of hydrocortisone
from HS over WS being both anhydrous bases is considered to be due to the
increased solubility of the drug in the former which is probably due to the solubilizing
effect of the emulsifying alcohols.
To study the effect of dilution on drug liberation, 1% WHS was diluted with the same
base, WHS, and the other bases in the ratios 1:1, 1:2 and 1:3.
For the facts that WHS and NHC possess similar microstructure, identical dissolving
capacity and release rate for hydrocortisone the diluted formulations of both bases
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revealed, as expected, similar liberation profiles. The relatively high release rates of
the preparations were attributed to the o/w character of the bases and the
significantly high saturation concentration of hydrocortisone. However, it is to be
noted that the liberation rates were higher than predicted for all mixing ratios. Since
all bases are suspension vehicles having identical amount of dissolved
hydrocortisone the factor influencing drug release in this case was considered to be
the variation in concentration gradient between the suspended and dissolved drug
upon dilution.
The dilution of WHS 1% with WWS 1:1 resulted in a quite high liberation rate if
compared with the dilutions 1:2 and 1:3. Conductivity and colouring tests showed that
this combination is still an o/w system, whereas increasing the amount of WWS in the
mixture converts it into a w/o one. However, this combination was not accompanied
by a respective increase in the drug solubility indicating that the influence of base type
being o/w exceeds in this case the effect of drug solubility on hydrocortisone release.
The great decrease in liberation of hydrocortisone, that was noticed upon dilution of
WHS 1% with HS at the ratio 1:1, despite of being still an o/w system, confirms that
hydrocortisone is dissolved to a great extent in the external aqueous phase.
Decreasing the amount of aqueous phase by that dilution therefore affected the drug
release negatively. When the amount of water was further decreased in the dilution
ratios 1:2 and 1:3 a phase conversion has taken place, which was accompanied by a
pronounced reduction in drug liberation.
Diluting WHS 1% with WS resulted in all combinations in very low liberation rates with
no significant difference, which indicates, that a phase conversion has taken place
already with the dilution ratio of 1:1. For the same reason the release of
hydrocortisone was drastically reduced when WHS 1% was diluted 1:1 with the
lipophilic vehicle, white petrolatum.
A comparative study on the formulations WHS/HS 1:1 and WHS/WS 1:1 with
WHS/white petrolatum 1:1 was undertaken to reveal the influence of adding a
hydrophilic and lipophilic emulsifier to white petrolatum, respectively. It was found that
the hydrophilic emulsifier in HS retained the o/w character of the base for that water
content (35%) besides, it increased the solubility of the drug in the base, resulting in
having the greatest liberation profile among the three formulations.
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Furthermore, it was noticed that diluting WWS 1% with WHS 1:1 showed exactly the
same liberation profile as the formulation WHS 1%/WWS 1:1. The same phenomenon
was observed for the formulations NHC 1%/WHS 1:1 and WHS 1%/NHC 1:1. In
conclusion, incorporating the drug in either of the two bases before dilution does not
affect drug release from the final formulation.
Moreover, WHS was prepared with different amounts of water in order to investigate
the effect of water content in hydrophilic bases on hydrocortisone release. Results
showed that the water content greatly influences drug release as long as the system
is an o/w one. However, very low water contents resulted in phase conversion after
which any variations in the amount of aqueous phase did not influence drug release.
In WHS the phase conversion took place between 30 and 35% water.
From the above-mentioned observation it seems surprising that NHC having only
50% water content releases hydrocortisone identical to WHS which contains 70%
water. This effect was considered to arise from differences in the type and amount of
emulsifier. Therefore, both bases with equal amounts of emulsifier (9%) and water
(50%) were tested for hydrocortisone release. Significant greater drug liberation and
solubility were noticed for NHC (9%) indicating thereby the greater influence of the
non-ionic surfactant in NHC over the anionic one in WHS on drug release and
solubility. However, comparing the release of NHC (9%) and NHC (15%) showed no
difference revealing the negligible effect of surfactant concentration. Furthermore, the
increased hydrocortisone release and solubility of NHC anhydrous over HS confirm
the effect of the emulsifier type on hydrocortisone solubility and release away from
any influence of the aqueous phase. Moreover, the fact that NHC anhydrous
possesses identical dissolving capacity for hydrocortisone to that of NHC (50%
water) indicates that water does not affect the drug solubility in bases emulsified by
non-ionic emulsifiers as does in vehicles containing ionic ones. This finding suggests
that the drug is present mainly in the structure of the base and not in the aqueous
phase unlike the case of WHS, besides it explains why NHC and WHS have identical
release rates despite of different water contents.
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5.2. Rheological experiments
In addition to base type, water content and drug solubility, the viscosity of the bases
was found to add further explanations for the different drug releasing profiles.
Oscillatory measurements were carried out to investigate the bases in their
viscoelastic range. In this range the structure of the base is undisturbed. The bases
were compared with regard to the complex viscosity, phase angle, storage modulus
and loss modulus.
For all the vehicles, 1% WHS, WWS, HS, WS and NHC the phase angle was below
45° indicating exceeding elastic behaviour. Water content was found to have no
influence on viscosity when incorporated inside the base as WS and WWS revealed
almost identical viscosities. In contrast, when water content constituted the external
phase it influenced the viscosity greatly as expressed in the significantly greater
viscosity of HS over WHS. These findings match with the releasing profiles of these
bases. Nevertheless, the well known rule that a decrease in viscosity is accompanied
by an increase in drug release was only partly verified. The lipophilic bases WWS
and WS in spite of having much lower viscosities than HS, they possessed lower
release rates for hydrocortisone. In this case the effect of base type and drug
solubility on drug release probably dominated over the effect of viscosity.
Furthermore, the greater viscosity of NHC over WHS, which is probably due to lower
water content in the former, does not agree with their identical liberation profiles. The
increase in viscosity was thought to compensate the drug release promoting effect of
the non-ionic emulsifier in NHC resulting in a release identical to that of WHS.
The significant increase in the phase angle - indicating increased viscous behaviour -
observed for all dilution ratios of WHS/WS and the combinations 1:2 and 1:3 of WHS
with both HS and WWS, was probably a result of the great structural change
associated with the phase conversion of all these vehicles from the o/w system to the
w/o one. Regarding the values of the storage and loss modulus however shows that
there is a great increase in the values of both, which means that the elasticity of the
vehicles greatly increased, too. This was accompanied by a great increase in
viscosity adding thereby a further explanation for the enormous drop in drug
liberation noticed for these formulations.
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It is worthy to note that, in contrast, all hydrophilic (o/w) bases – all dilution ratios of
WHS/NHC and the 1:1 combination of WHS/HS and WHS/WWS- revealed an
insignificant change in the phase angle. This does not mean that the viscous and
elastic behaviour of these vehicles remained constant as the values of both moduli
also increased. The increase of their values was however in a balanced manner so
that the ratio between viscous and elastic properties remained almost constant.
For these bases being o/w systems their viscosities are greatly affected as shown
above by the water content unlike the w/o preparations. This finding explains the
greater viscosity of WHS/HS 1:1 having 35% aqueous phase over that of WHS/WWS
1:1 with 60% water content. This is probably the reason why the latter had a
significant greater release rate than the former despite of its lower solubility for
hydrocortisone.
Nevertheless, the significant greater solubility of hydrocortisone in WHS/NHC 1:1
over WHS/WWS 1:1 is probably the reason behind its greater drug release despite of
its greater viscosity, which is completely opposing the case mentioned above.
Reducing the amount of the non-ionic emulsifier in NHC from 15 – 9% did not alter
the drug solubility and release, as shown before, which was therefore interpreted as
the negligible influence of this change in surfactant concentration on hydrocortisone
liberation. Surprisingly the decreased amount of surfactant, however, resulted in a
significant decrease in viscosity, which would let us rather expect an increase in drug
release. These results strongly suggest that the emulsifier not only improves the drug
solubility, but also plays a role in facilitating the drug release. Therefore, the decrease
in surfactant concentration in NHC (9%), i.e. decrease in the drug release promoting
effect, was probably compensated by the decrease in viscosity resulting in identical
drug release to that of NHC (15%).
Taken altogether the drug release is affected by a number of factors. These factors
can be summarized as follows:
a) Factors promoting drug release: type of base being o/w, increased drug
solubility, increased water content in o/w bases and decreased viscosity.
b) Factors limiting drug release: type of base being w/o, decreased drug
solubility, decreased water content in o/w bases and increased viscosity.
These facts are true for most cases, however sometimes not all factors affect the
drug release in one direction i.e. some factors promote drug liberation whereas other
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factors limit it. In this case the effect of one of the factors either exceeds the effect of
the others or the opposing factors are equally strong so that they compensate each
other. This can not be expected in advance and is greatly case-dependent.
5.3. Permeation experiments
Permeation experiments were carried out in order to investigate the influence of the
different base types and their dilutions on drug permeation. The permeation of
hydrocortisone was tested through excised human stratum corneum, which presents
the main barrier of the skin. To be able to correlate the permeation experiments to
the release experiments the same vehicles were used.
All vehicles were found to have similar permeation profiles for hydrocortisone i.e. all
the factors affecting drug release like base type, water content, drug solubility and
viscosity of the base had no influence on drug permeation through excised stratum
corneum. The lack of correlation between release and permeation experiments is
also reported by many authors (Lippold, 1984; Zatz et al., 1996; Alberg, 1998). On
the other hand, this result may not agree with other studies (Shah et al., 1991) which
report a greater drug permeation for ointments. However, this increased drug
permeation observed for ointments is due to their occlusive effect which can
unfortunately not be detected by this in vitro method. Equation 4.5 states that in case
of suspension vehicles the factor directly influencing drug permeation is the
saturation concentration of the drug in stratum corneum not that in the vehicle,
therefore different base types with different drug solubilizing capacities do not affect
drug permeation. Consequently, all the 1:1 and 1:3 diluted vehicles revealed very
close permeation profiles with no significant differences. Furthermore, the permeation
rates of the diluted formulations lay in the same range of that of WHS 1%, revealing
thereby the negligible influence of dilution on hydrocortisone permeation. This was
attributed to the fact that all diluted bases are still suspension vehicles i.e. dilution
does not reduce drug concentration below its degree of saturation. For this the
concentration of hydrocortisone in stratum corneum remains unchanged,
subsequently its permeation.
In contrast, hydrocortisone was found to permeate significantly greater from Soventol
cream than from WHS. This was believed to be due to the enhancing effect of
isopropyl myristate which is present in Soventol cream. For all the above-mentioned
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findings the considerable reduction of hydrocortisone permeation following the
dilution of Soventol cream 1:2 with WHS is believed to be due to reduced enhancer
concentration and not that of the drug.
The findings obtained in the present study substantiated by the respective literatures
allow us to conclude that dilution may affect drug permeation through stratum
corneum in the following cases:
1- Changing the occlusive properties of the base by diluting it with a different base
type.
2- The presence of an enhancer in either of the 2 bases (the diluent or/and the
original base)
3- When the drug is completely dissolved in the base, or in case of diluting a
suspension vehicle below its degree of saturation, the drug solubility in stratum
corneum may be affected upon dilution.
5.4. Influence of vehicle on structure of stratum corneum
In the present study the interactions between vehicle and stratum corneum were
investigated using differential scanning calorimetry and wide angle x-ray
diffractometry. It is well known that the lipoidal structure of stratum corneum is
responsible for its barrier properties (Golden et al., 1987 a). Hence, an alteration in
the lipoidal structure would indicate an increase in the permeability of the barrier
towards invasive substances. The lack of interaction between the components of
WHS, WS, WWS, HS and NHC and the lipid bilayers of stratum corneum proven by
both techniques therefore explains why all these vehicles showed similar permeation
profiles for hydrocortisone.
On the other hand, a significant shift of the lipid phase transitions of stratum corneum
was observed upon pretreating the stratum corneum with Soventol cream. This was
also confirmed by the WAXD technique showing an analogous shift in the diffraction
rings characteristic for the intercellular lipid domains. These findings indicate the
disruption of the packing of the intercellular lipids of stratum corneum. Isopropyl
myristate, which is known to act as a penetration enhancer, was proven to be
responsible for these effects as it exhibited similar shifts of the phase transition
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temperatures. This phenomenon may be interpreted as an increase in the fluidity of
the lipid bilayers. The reason for the fluidizing effect of isopropyl myristate might be
its branched structure, which may cause a decrease of the ordered structure of the
lipid lamellae. Moreover, isopropyl myristate is able to dissolve considerable amounts
of cholesterol (Leopold, 1992), which may act as a membrane stabilizer (Imokawa, et
al., 1989). In conclusion, the increased permeability of hydrocortisone from Soventol
cream in comparison to WHS is attributed to the increased disorder of the stratum
corneum structure caused by isopropyl myristate.
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6. Summary
Dilution of semisolid preparations, in order to tailor the formulations to the needs of
the patients, was thought to be associated with a number of dangers, one of which is
the unpredictable reduction of activity. In the present study the influence of dilution on
hydrocortisone liberation and permeation through excised human stratum corneum
was investigated. Furthermore, the factors affecting both processes and their
correlation were examined. Water containing hydrophilic ointment DAB (1998) with
1% hydrocortisone was taken as a model cream; it was diluted with various bases
possessing different compositions and properties.
The type of the base, was found to be one of the most important factors affecting
drug release. The liberation profiles of hydrocortisone from o/w systems were
significantly greater than from anhydrous bases and lipophilic vehicles. This was
believed to be due to free and fast release of the drug from the external aqueous
phase. Moreover, for all the investigated vehicles being suspension-type, the degree
of hydrocortisone solubility had also a direct influence on drug release. Almost all
vehicles showing high liberation rates exhibited relatively high saturation
concentrations of hydrocortisone. An additional factor playing a direct role in drug
release is the rheological behaviour of the bases. The investigations were carried out
using oscillatory measurements, which examine the vehicles in their linear
viscoelastic range. The o/w systems were characterized by having relatively low
viscosities, which add a further explanation for their great liberation profiles. Diluting
the o/w base with lipophilic or anhydrous hydrophilic bases resulted in a phase
conversion to the w/o system. This was associated with a great increase in viscosity
and very low liberation rates. Furthermore, water content when present in o/w
systems revealed a significant influence on drug liberation. The increased water
content raised in most cases the amount of dissolved drug and decreased the
viscosity; both resulted in increased hydrocortisone liberation. Moreover, it was found
that the non-ionic emulsifiers in o/w vehicles promoted drug release over the anionic
ones.
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The results obtained from the permeation studies revealed the lack of correlation
between liberation and permeation studies, i.e. all factors which were found to affect
hydrocortisone release like base type, drug solubility and viscosity had no influence
on drug permeation resulting in no significant differences in the drug permeation from
the various cream bases studied. In conclusion, the permeability of stratum corneum,
which was not affected by the cream bases as shown by DSC and WAXD
experiments, is the rate limiting step for drug permeation. Furthermore, the dilution
did not result in any reduction in drug permeation, which was referred to the fact that
all diluted bases are still suspension vehicles. In contrast to WHS, hydrocortisone
was found to permeate significantly greater from Soventol cream (placebo with 1%
hydrocortisone), which is known to contain isopropyl myristate as permeation
enhancer. DSC experiments showed that the pretreatment of human stratum
corneum with 1% Soventol cream as well as with isopropyl myristate revealed a
significant shift in the lipid phase transitions of about 5°C to lower temperatures. This
shift indicates an alteration in the lipoidal structure of stratum corneum, which is
known to be responsible for its barrier properties subsequently leading to an increase
in permeability. Moreover, the 1:2 dilution of Soventol cream with WHS revealed a
considerable reduction of hydrocortisone permeation.
In conclusion, dilution of suspension-type cream bases could indeed reduce drug
permeation in the case they contain a penetration enhancer. However, this reduction
in drug permeation could be in an unpredictable manner i.e. the 1:2 dilution of
Soventol cream resulted in a 1:5 reduction in drug permeation. The reduced
hydrocortisone permeation from the diluted formulation is believed to be due to
reduced enhancer concentration.
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